var title_f1_58_1952="Isolated uncomplicated fracture of the medial malleolus";
var content_f1_58_1952=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74497&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74497&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Isolated uncomplicated fracture of the medial malleolus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A fracture of the medial malleolus (white arrow) is clearly seen on this view. Care must be taken to exclude additional injuries (eg, proximal fibular fracture) commonly&nbsp;associated with fractures of the medial or posterior malleoli.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott M Koehler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1952=[""].join("\n");
var outline_f1_58_1952=null;
var title_f1_58_1953="DBE NSAID ulcerations";
var content_f1_58_1953=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72227&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72227&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    DBE NSAID ulcerations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nonsteroidal antiinflammatory drug (NSAID)-induced superficial mid-ileal ulcerations diagnosed by double balloon enteroscopy (DBE).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Louis-Michel Wong Kee Song, MD, FRCP(C).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1953=[""].join("\n");
var outline_f1_58_1953=null;
var title_f1_58_1954="Intestinal metaplasia of the distal esophagus";
var content_f1_58_1954=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intestinal metaplasia of the distal esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power view of a biopsy specimen from the distal esophagus revealed intestinal metaplasia diagnostic of Barrett's esophagus. The diagnostic feature is the presence of goblet cells (arrow), characterized by apical basophilic cytoplasm, a dilated lateral cell border and a compressed basal nucleous.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Donald Antonioli, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1954=[""].join("\n");
var outline_f1_58_1954=null;
var title_f1_58_1955="Trolamine: Drug information";
var content_f1_58_1955=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Trolamine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?22/47/23284?source=see_link\">",
"    see \"Trolamine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F230990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aspercreme&reg; [OTC];",
"     </li>",
"     <li>",
"      Flex-Power [OTC];",
"     </li>",
"     <li>",
"      Mobisyl&reg; [OTC];",
"     </li>",
"     <li>",
"      Myoflex&reg; [OTC];",
"     </li>",
"     <li>",
"      Sportscreme&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F230991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Antiphlogistine Rub A-535 No Odour;",
"     </li>",
"     <li>",
"      Myoflex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F230996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic, Topical;",
"     </li>",
"     <li>",
"      Salicylate;",
"     </li>",
"     <li>",
"      Topical Skin Product",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F230992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Pain:",
"     </b>",
"     Topical: Apply to affected area as needed up to 3-4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F11587746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F230993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F230985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical, as salicylate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aspercreme&reg;: 10% (35 g, 85 g, 142 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Flex-Power: 10% (57 g, 113 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mobisyl&reg;: 10% (100 g, 227 g) [contains almond oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Myoflex&reg;: 10% (57 g, 113 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sportscreme&reg;: 10% (35 g, 85 g) [contains tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lotion, topical, as salicylate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aspercreme&reg;: 10% (180 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F230978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Cream",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F11587747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May wrap affected area loosely with a 2-3 inch elastic bandage.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F230986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of pain of muscular aches, rheumatism, neuralgia, sprains, arthritis on intact skin",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F231000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Myoflex&reg; may be confused with Mycelex",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Biafine: Brand name for trolamine [multiple international markets], but also the brand name for a topical emulsion [U.S.]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F230994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Confusion, drowsiness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting, diarrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Hyperventilation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F11587744\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Self-medication (OTC use): Do not use on irritated skin or near eyes. Stop use and call healthcare provider if irritation occurs or if conditions worsen, persist &gt;7 days, or clear up then worsen again in a few days.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14446401\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Systemic absorption of salicylate occurs following topical administration of trolamine (Rabinowitz, 1984).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16324031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Aspercreme/Aloe External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% (85 g): $4.91",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Exocaine Medicated Rub External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% (90 g): $3.46",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Mobisyl External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% (100 g): $5.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Myoflex External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% (57 g): $4.18",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Sportscreme External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% (85 g): $4.32",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lotion",
"     </b>",
"     (Aspercreme External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% (177.4 mL): $4.91",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lotion",
"     </b>",
"     (Aspercreme Nighttime External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% (141 g): $6.50",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F230988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Biafine (AR, CH, CL, CN, EC, FR, IL, PE, PT, SG, VE);",
"     </li>",
"     <li>",
"      Lamiderm (BE)",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Hochberg MC, Altman RD, April KT, et al, &ldquo;American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee,&rdquo;",
"      <i>",
"       Arthritis Care Res (Hoboken)",
"      </i>",
"      , 2012, 64(4):465-74.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/58/1955/abstract-text/22563589/pubmed\" id=\"22563589\" target=\"_blank\">",
"        22563589",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rabinowitz JL and Baker D, \"Absorption of Labeled Triethanolamine Salicylate in Human and Canine Knee Joints. II,\"",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 1984, 24(11-12):532-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/58/1955/abstract-text/6334699/pubmed\" id=\"6334699\" target=\"_blank\">",
"        6334699",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10302 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-189.41.181.191-2D925142A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1955=[""].join("\n");
var outline_f1_58_1955=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230990\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230991\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230996\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230992\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11587746\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230993\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230985\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230978\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11587747\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230986\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231000\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230994\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11587744\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300182\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223541\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14446401\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16324031\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230988\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10302\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10302|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/47/23284?source=related_link\">",
"      Trolamine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_58_1956="Clear cell carcinoma CT";
var content_f1_58_1956=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Computed tomographic (CT) image of large clear cell carcinoma of the kidney",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial contrast-enhanced CT image shows a large enhancing mass in the left kidney with central necrosis (asterisk). A patent left renal vein (arrow) is noted medially. A low grade (Furhman nuclear grade 2) clear-cell renal cell carcinoma was identified pathologically after nephrectomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ivan Pedrosa, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1956=[""].join("\n");
var outline_f1_58_1956=null;
var title_f1_58_1957="Toxoplasma gondii cysts";
var content_f1_58_1957=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58280&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58280&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 532px\">",
"   <div class=\"ttl\">",
"    Unstained and stained Toxoplasma gondii cysts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 512px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cysts of Toxoplasma gondii usually range in size from 5-50 micrometers in diameter. They may be found in various sites throughout the body of the host, but are most common in the brain and skeletal and cardiac muscles. Cysts are usually spherical in the brain but more elongated in cardiac and skeletal muscles.",
"    <br>",
"     (A) Unstained cyst of T. gondii.",
"     <br>",
"      (B) Toxoplasma gondii cyst in brain tissue stained with hematoxylin and eosin.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced from: Centers for Disease Control and Prevention Center for Global Health. Parasite Image Library. Available at: file://www.dpd.cdc.gov/dpdx/HTML/Image_Library.htm. Accessed on December 15, 2010.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1957=[""].join("\n");
var outline_f1_58_1957=null;
var title_f1_58_1958="Intraluminal lesion CT";
var content_f1_58_1958=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F75874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F75874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Computed tomographic scans with intraluminal tracheal lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 500px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upper panel shows an incidental finding of a mucus plug (red arrow) in the trachea. In contrast, the lower panel demonstrates a mucosal tracheal metastasis (blue arrow) from adenocarcinoma of the lung in a patient status post right upper lobe lobectomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1958=[""].join("\n");
var outline_f1_58_1958=null;
var title_f1_58_1959="Painful and thermal pathways";
var content_f1_58_1959=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61109&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61109&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 569px\">",
"   <div class=\"ttl\">",
"    Some pathways concerned with transmission of impulses activated by peripheral painful and thermal stimuli",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 549px; height: 448px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Entering peripheral nerve fibers ascend and descend several segments and then cross over to ascend to the thalamus on the opposite side of entry (L: lower extremity; U: upper extremity; F: face). (B) Many fibers terminate in the mesencephalon. Layering of fibers in the lateral spinothalamic tract is shown in (C) and details of synapses in (D). Pain and temperature fibers from the face descend from the midpontine level to the upper cervical levels before postsynaptic fibers synapse and cross to the opposite side.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Wilderholt, WC, Neurology for Non-neurologists, 4th ed, WB Saunders, Philadelphia 2000. Copyright &copy; 2000 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1959=[""].join("\n");
var outline_f1_58_1959=null;
var title_f1_58_1960="Hallux valgus deformity (bunion)";
var content_f1_58_1960=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hallux valgus deformity (bunion)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/58/1960/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/58/1960/contributors\">",
"     Jill Ferrari, PhD, BSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/58/1960/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/58/1960/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/58/1960/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/58/1960/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/58/1960/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Valgus malformation of the great toe, commonly known as a bunion, is a very common and potentially painful and debilitating condition of unclear etiology. This topic review will provide an overview of the relevant anatomy, pathophysiology, diagnosis, and management of hallux valgus. Toe and foot injuries are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44358?source=see_link\">",
"     \"Toe fractures in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12614?source=see_link\">",
"     \"Metatarsal shaft fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RELEVANT ANATOMY AND BIOMECHANICS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Basic forefoot anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;By convention, toes and their respective metatarsals are numbered from one (great toe) through five (little toe). The great toe has two phalanges, while the second through fifth toes typically have three (",
"    <a class=\"graphic graphic_figure graphicRef78924 \" href=\"UTD.htm?30/7/30835\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef61079 \" href=\"UTD.htm?37/40/38530\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef71857 \" href=\"UTD.htm?2/20/2375\">",
"     figure 3",
"    </a>",
"    ). Tendons and ligaments insert at the bases of each phalanx. The digital artery and nerve pass together along each side of each toe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Definitions",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hallux valgus deformity &ndash; This deformity is defined as a lateral deviation of the hallux (great toe) on the first metatarsal (",
"      <a class=\"graphic graphic_figure graphicRef64417 \" href=\"UTD.htm?33/12/33987\">",
"       figure 4",
"      </a>",
"      ). The deviation of the hallux occurs primarily in the transverse plane. The deformity often also involves rotation of the toe in the frontal plane causing the nail to face medially (ie, eversion). These two deviations have led to the use of different terms to describe the deformity. In orthopedic texts, it is often called \"hallux valgus\" (HV) whereas many podiatry texts prefer the term \"hallux abductovalgus (HAV).\" The public is more familiar with the expression \"bunion.\"",
"     </li>",
"     <li>",
"      Hallux abductus (or hallux valgus) angle &ndash; The angle created by the bisection of the longitudinal axis of the hallux and the longitudinal axis of the first metatarsal (",
"      <a class=\"graphic graphic_figure graphicRef64417 \" href=\"UTD.htm?33/12/33987\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76005 \" href=\"UTD.htm?19/51/20275\">",
"       image 1",
"      </a>",
"      ). Historically, a hallux abductus (HA) angle of greater than 15 degrees was considered abnormal, but such deformities are not always symptomatic, and some cases of an HA angle greater than 15 degrees occur naturally due to the shape of the articular surfaces involved [",
"      <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. Contemporary research suggests an HA angle of 20 degrees or greater is abnormal [",
"      <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intermetatarsal (IM) angle &ndash; The angle determined by the bisection of the longitudinal axes of the first and second metatarsals (",
"      <a class=\"graphic graphic_figure graphicRef64417 \" href=\"UTD.htm?33/12/33987\">",
"       figure 4",
"      </a>",
"      ). An IM angle less than 9 degrees is considered normal.",
"     </li>",
"     <li>",
"      Ray &ndash; The forefoot consists of five longitudinal projections, called rays, which are comprised of the metatarsal and its respective phalanges, and the bones aligned with and proximal to the metatarsal, such as the cuneiforms or cuboid bones. Hallux valgus involves the first ray.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     First ray anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;No muscles originate on the first metatarsal and insert into the phalanx to directly stabilize the first metatarsophalangeal (MTP) joint. The abductor and adductor hallucis muscles pass medially and laterally to the MTP joint respectively, but they are located nearer to the plantar surface (",
"    <a class=\"graphic graphic_figure graphicRef52955 \" href=\"UTD.htm?3/57/3990\">",
"     figure 5",
"    </a>",
"    ). Thus, any force pushing the proximal phalanx laterally, or the metatarsal head medially, is relatively unrestrained and can create a valgus deformity.",
"   </p>",
"   <p>",
"    The first metatarsal is held in alignment by a splinting action of the abductor hallucis muscle medially and by the lateral pull of the peroneus longus acting at the base of the metatarsal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/4\">",
"     4",
"    </a>",
"    ]. Movement at the first MTP joint in the transverse plane is prevented by collateral ligaments running from the metatarsal epicondyles, distally and plantarly, to the proximal phalanx.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pathophysiology of HV deformity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The metatarsocuneiform joint has a sinusoidal curve allowing medial-dorsal and plantar-lateral movements. Increased pressure under the head of the first metatarsal (for example, due to increased subtalar pronation or a congenital plantar-flexed first ray) will force the metatarsal to move medial-dorsally. This movement increases the HA and IM angles and places the metatarsal more medial relative to its proximal phalanx. As muscle action stabilizes the joint during gait, pressure from the proximal phalanx on the lateral aspect of the metatarsal head pushes the metatarsal more medially, further increasing the HA angle.",
"   </p>",
"   <p>",
"    As the first metatarsal moves medially and the hallux moves laterally, the medial capsule and medial collateral ligament come under chronic strain and eventually rupture. The medial movement of the metatarsal forces the abductor hallucis muscle beneath the metatarsal. From this position it acts solely as a plantar-flexor of the proximal phalanx, thereby contributing to the valgus rotation seen with HV deformity. Eventually, without medial stabilizing structures, the lateral joint capsule and collateral ligaments tighten and the adductor hallucis muscle acts unopposed, exacerbating the deformity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since not all cases of HV deformity become severe, there may be a threshold up to which the forces deforming the joint can be opposed by other anatomic structures. When forces greater than the threshold occur, the joint becomes deformed. It is possible that such progression occurs rapidly rather than worsening steadily over several years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/1,2,6\">",
"     1,2,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many studies have tried to determine the prevalence of hallux valgus (HV) deformity. Approximately 4 to 44 percent of women and 2 to 22 percent of men have HV deformity, depending upon the method of measurement and the population studied [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/7-14\">",
"     7-14",
"    </a>",
"    ]. The prevalence is greater among shod compared with barefoot populations, although the condition is still found twice as often in women than men in non-shod populations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many theories have been proposed, but the precise etiology of hallux valgus (HV) deformity is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/18\">",
"     18",
"    </a>",
"    ]. Most likely, HV deformity is multifactorial in origin and includes such factors as: abnormal foot mechanics affecting the first ray [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/5,19-23\">",
"     5,19-23",
"    </a>",
"    ], abnormal first metatarsophalangeal anatomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/24-27\">",
"     24-27",
"    </a>",
"    ], joint hypermobility [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/28,29\">",
"     28,29",
"    </a>",
"    ], and genetic influences [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/4\">",
"     4",
"    </a>",
"    ]. HV is also associated with conditions such as inflammatory joint disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/30-32\">",
"     30-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since HV deformity occurs primarily in shod populations, affecting women in particular, poor footwear has frequently been cited as a cause. The fact that some women wear footwear that compresses their toes significantly without detrimental effects, while some men suffer from marked HV deformity despite the use of sensible footwear, leads many to think that footwear probably exacerbates underlying bony or mechanical abnormalities rather than acting as a primary factor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although hallux valgus (HV) is easily recognized by clinical examination, x-rays may be necessary to determine the presence of damage to the articular surfaces of the first metatarsophalangeal (MTP) joint. Surgeons use radiographs to assess the severity of the deformity and select the appropriate procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Associated findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;HV can lead to a number of painful complications in or around the first MTP joint, including [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inflammation of a medial bursa protecting the joint (most common)",
"     </li>",
"     <li>",
"      Degeneration of the crista on the plantar surface of the metatarsal head, caused by erosion as the metatarsal moves over the sesamoids",
"     </li>",
"     <li>",
"      Entrapment of the medial dorsal cutaneous nerve as it passes through the enlarged bunion area",
"     </li>",
"     <li>",
"      Hammertoe deformity of the second toe, caused by destabilizing pressure from the laterally deviated great toe",
"     </li>",
"     <li>",
"      Central metatarsalgia, caused by the patient's chronic shifting of weight from an unstable first ray onto the central rays",
"     </li>",
"     <li>",
"      Degeneration of the cartilage covering the metatarsal head",
"     </li>",
"     <li>",
"      Synovitis of the MTP joint",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hyperkeratosis may also occur as a result of altered weightbearing forces and can cause marked discomfort. Assessment of HV to determine the factors causing patient discomfort is important, as it will help to determine the appropriate treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hundreds of studies have been published assessing numerous conservative and surgical treatments for hallux valgus (HV) deformity. Overall, there is little evidence that conservative treatments are useful. Nevertheless, we agree with the American College of Foot and Ankle Surgeons and suggest that patients make use of conservative therapies before surgical referral is made [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with severe pain or dysfunction and those whose symptoms do not improve under a conservative regimen should be referred to a foot surgeon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Conservative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few randomized trials looking at conservative treatments for HV in adults have been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/37\">",
"     37",
"    </a>",
"    ]. Despite the dearth of evidence, we suggest the following nonoperative treatments be considered to alleviate symptoms and possibly to help prevent progression of HV deformity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/36\">",
"     36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Shoe modification: wide, low-heeled shoes, or specially altered shoes with increased medial pocket for the first metatarsophalangeal (MTP) joint to minimize deforming forces",
"     </li>",
"     <li>",
"      Orthoses to improve support and alignment",
"     </li>",
"     <li>",
"      Night splinting to improve toe alignment",
"     </li>",
"     <li>",
"      Stretching",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       mobilization/manipulation",
"      </span>",
"      to maintain joint mobility",
"     </li>",
"     <li>",
"      Medial bunion pads to prevent irritation",
"     </li>",
"     <li>",
"      Ice applied after activity to reduce inflammation",
"     </li>",
"     <li>",
"      Analgesics:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      or NSAIDs",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Orthoses",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the treatment of HV deformity, orthoses are used to improve foot mechanics (eg, reducing abnormal subtalar joint pronation) and to prevent abnormal forces from acting on the first ray complex. It is hoped that orthoses might prevent deterioration of the HV angle and relieve pain by improving joint function. Orthoses need to be worn in a well-fitting, low-heeled, fastening shoe, and this type of shoe may itself influence joint position and discomfort.",
"   </p>",
"   <p>",
"    In subjects with rheumatoid arthritis (RA), orthoses have been shown to prevent progression of HV deformity compared with controls with RA and placebo orthoses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/38\">",
"     38",
"    </a>",
"    ]. The Hallux abductus (HA) angle progressed in 10 percent of the treatment group compared with 25 percent of the control group (adjusted odds ratio = 0.27) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/38\">",
"     38",
"    </a>",
"    ]. In the same study, however, measures of pain, disability, and function of the foot showed little difference between patients wearing orthoses and those wearing placebo devices. Furthermore, the majority of patients in the trial were male, and these results may not apply to women, who comprise the majority of patients with HV deformity.",
"   </p>",
"   <p>",
"    When orthoses were compared with no treatment in patients with painful, mild-to-moderate HV deformity, patients wearing orthoses reported improved pain scores after six months, but these improvements were not maintained thereafter [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/39\">",
"     39",
"    </a>",
"    ]. At one year, only the global assessment score remained better in the orthosis group (46 percent better than one year ago versus 24 percent; 11 percent worse than one year ago versus 34 percent). In the same study, surgery (chevron osteotomy) outperformed orthoses for all outcomes. The study did not evaluate HA angle progression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Splinting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splints can be used to place the toe in a corrected position in the hope of enabling soft tissue adaptation and delaying rupture of the medial joint capsule and collateral ligament. The most common devices used are night splints, which realign the hallux while nonweightbearing (",
"    <a class=\"graphic graphic_picture graphicRef57494 \" href=\"UTD.htm?0/57/913\">",
"     picture 1",
"    </a>",
"    ). Wedges placed between the first and second toe (toe separator) and attached with adhesive strapping are also used.",
"   </p>",
"   <p>",
"    Studies of splinting for hallux valgus are limited. Night splints were ineffective in reducing pain associated with HV deformity in one small randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/40\">",
"     40",
"    </a>",
"    ]. Progression of the deformity did not occur in the treatment or the control group over the six-month trial duration. Night splints were more effective in reducing deformity and pain than a toe separator, but they were less effective than exercises, in another small study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/41\">",
"     41",
"    </a>",
"    ]. However, the mean decrease in HA angle was approximately 2 degrees, which was within the range of measurement error. A study of 30 patients comparing night splints to a toe separator attached to a semi-rigid insole reported a significant reduction in pain intensity at three months in the group using the toe separator insole, but changes in HA and IMA angles were not significantly different [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1633258\">",
"    <span class=\"h3\">",
"     Mobilization and manipulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The results of two small preliminary studies suggest that graded mobilization and manipulation may improve pain and function in the short term, but further study of the long term effects is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Marigold ointment was reported to be effective in reducing pain, soft tissue swelling, and the HA angle when applied to the bunion area over an eight-week period [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral for surgical repair is based primarily upon patient symptoms (eg, pain, difficulty with ambulation); neither clinical nor radiographic appearance plays a significant role. Patients with severe pain or dysfunction and those whose symptoms do not improve under a conservative treatment regimen should be referred to a foot surgeon. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Conservative management'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Approximately 150 surgical procedures for the correction of HV deformity have been described. All involve one of the following basic approaches:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fusing the metatarsophalangeal (MTP) joint or the metatarsocuneiform joint in a corrected position (arthrodesis)",
"     </li>",
"     <li>",
"      Removing the joint or replacing the joint with an implant (arthroplasty)",
"     </li>",
"     <li>",
"      Cutting the first metatarsal and realigning the bone in a less adducted position (osteotomy)",
"     </li>",
"     <li>",
"      Removing the prominent side of the metatarsal head (bunionectomy)",
"     </li>",
"     <li>",
"      Reconstruction of soft tissue to pull the bones into a corrected position (tenotomy)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are many retrospective studies but very few prospective, randomized trials evaluating these procedures. A systematic review from 2003 identified 15 randomized trials concerned with surgical correction of the deformity, but noted that trial sizes were small and the quality generally poor [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/37\">",
"     37",
"    </a>",
"    ]. Although patient satisfaction with surgical correction ranges from 50 to 90 percent, the trend is toward greater satisfaction as surgical techniques have improved.",
"   </p>",
"   <p>",
"    Both orthopedic and podiatric specialist foot surgeons, as well as nonspecialists, perform operations to repair HV deformity. No study has compared the results of surgery based on who performed the procedure. Nevertheless, we suggest patients be referred to a foot surgery specialist with experience repairing HV deformity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Patient satisfaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient satisfaction does not appear to correlate with surgical outcome as determined by radiographic parameters (ie, HA and IM angles) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/46\">",
"     46",
"    </a>",
"    ]. Some patients have a misapprehension that the hallux should be straight after the operation. Others may be under the mistaken impression that they will be able to fit into narrower shoes postoperatively and can be dissatisfied if this expectation is not met.",
"   </p>",
"   <p>",
"    Managing patient expectations is important. Patients should understand that 10 to 25 degrees of valgus angulation is normal at the MTP joint, and that resolution of postoperative pain and swelling may require several months [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/47\">",
"     47",
"    </a>",
"    ]. Most will remain unable to fit into narrower shoes. One study found that only 2 of 52 patients could wear smaller shoes after their procedure, despite a postoperative reduction in foot width [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Arthrodesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fusion of the first MTP joint is rarely performed, unless there is severe degeneration of the joint and good function is unlikely to be regained were only joint position corrected. The procedure is usually reserved for older patients. Walking on a fused MTP joint alters foot mechanics during gait and can cause secondary hyperkeratoses to develop.",
"   </p>",
"   <p>",
"    A study of 81 patients treated with first MTP arthrodesis reported success in relieving joint pain, improving walking distance, and improving appearance after a minimum follow-up of 24 months [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fusion at the metatarsocuneiform joint is called the Lapidus procedure and is used when the mobility of the first ray is excessive. A study of 87 patients found that the Lapidus procedure combined with a soft tissue correction was successful in reducing the HA and IM angles, as well as improving the American Orthopaedic Foot and Ankle Society (AOFAS) functional score [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/50\">",
"     50",
"    </a>",
"    ]. Eighty-four percent of patients considered the surgery satisfactory.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Arthroplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comparison of arthrodesis with Keller's arthroplasty found that 75 percent of the arthroplasty patients were completely satisfied postoperatively, and that 88 percent experienced complete pain relief [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/49\">",
"     49",
"    </a>",
"    ]. However, 12 percent experienced worse pain after the surgery. The authors also found the response to surgery could be prolonged, with some patients needing up to 30 months before manifesting improvement. Overall, little difference in outcomes was found between the arthroplasty and arthrodesis groups.",
"   </p>",
"   <p>",
"    A small study comparing distal metatarsal osteotomy with Keller's arthroplasty found larger residual HA and IM angles in the arthroplasty group, but overall satisfaction and pain relief did not differ significantly [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Osteotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cut made in the bone during an osteotomy varies in shape and position, depending upon the surgical strategy. As an example, a straight cut is used in the Wilson osteotomy whereas a wedge-shaped cut is used in the chevron osteotomy. The cut may be made near the neck of the metatarsal (distal osteotomy) or near the base (proximal osteotomy). Although a greater degree of correction is possible through proximal osteotomies, these procedures require larger dissections and have higher complication rates. Generally, the surgeon tries to minimize metatarsal shortening and to maintain the metatarsal's plantar-flexed position.",
"   </p>",
"   <p>",
"    The chevron osteotomy has been studied most closely:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial involving 209 patients that compared chevron osteotomy to treatment with orthosis and to no treatment found that osteotomy outperformed nonoperative alternatives [",
"      <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/39\">",
"       39",
"      </a>",
"      ]. At 12-month follow-up, the HA and IM angles in the osteotomy group were at normal values, and 80 percent of patients were satisfied with their treatment. Nevertheless, 61.5 percent of the surgical patients still had \"moderate\" footwear problems, and half had experienced some pain in the previous six months. Over the 12-month follow-up period, the surgery group also had the highest costs for foot care and took the greatest number of sick days.",
"     </li>",
"     <li>",
"      In another randomized trial comparing the chevron osteotomy (n = 70) with the scarf osteotomy (n = 66), no significant difference was found in radiologic appearance, functional outcome scores, or patient satisfaction among those with mild to moderate deformity [",
"      <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/52\">",
"       52",
"      </a>",
"      ]. Among the 12 patients with severe deformity, the chevron osteotomy appeared to provide greater correction based on radiologic appearance.",
"     </li>",
"     <li>",
"      When the chevron osteotomy (n = 50) was compared to the Lindgren osteotomy (n = 50) in a randomized controlled trial, patients treated with a chevron procedure had a significantly greater HV angle at both 1 year and 4.7 year follow-up, although this angle was only just beyond normal range (chevron HV angle mean = 21 degrees) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/53\">",
"       53",
"      </a>",
"      ]. There was no significant difference in IM angles or in pain scores between groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A prospective nonrandomized comparison of distal metatarsal osteotomy and Keller's arthroplasty reported better radiologic outcomes in the osteotomy group, but patient satisfaction scores were similar [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/51\">",
"     51",
"    </a>",
"    ]. The authors commented that 60 percent of the patients were over 60 years old and that good surgical outcomes can be achieved in older patients.",
"   </p>",
"   <p>",
"    Proximal osteotomy appears to be more effective at correcting both the HA and IM angles but results in a shorter metatarsal and higher complication rates [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/46\">",
"     46",
"    </a>",
"    ]. Patient satisfaction with each procedure was 97 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Soft tissue procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;No study has evaluated soft issue procedures to correct HV deformity independently. The McBride procedure primarily involves soft tissue surgery. &nbsp;",
"   </p>",
"   <p>",
"    One study of 31 patients compared the effect of transposition of the adductor hallucis muscle to the lateral metatarsal head to leaving the tendon detached and reported no significant difference in HA or IM angles in the two groups [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/54\">",
"     54",
"    </a>",
"    ]. Another small study compared chevron-Akin osteotomy to a distal soft tissue reconstruction-Akin osteotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/55\">",
"     55",
"    </a>",
"    ]. Although the soft tissue reconstruction did not correct the HA and IM angles as well as the osteotomy alone, patient satisfaction did not differ significantly.",
"   </p>",
"   <p>",
"    A study of 84 patients compared the chevron osteotomy with the chevron plus adductor tenotomy and found no significant difference in patient satisfaction and little difference in mechanical correction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/56\">",
"     56",
"    </a>",
"    ]. Another study of 86 patients comparing the chevron osteotomy with and without soft tissue release also reported no significant difference in HA or IM angles at one year follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1960/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/50/29473?source=see_link\">",
"       \"Patient information: Bunion (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hallux valgus (HV) deformity (ie, bunion) is a common, potentially debilitating deformity consisting of lateral deviation of the hallux on the first metatarsal. The etiology is unknown. The deformity is more common among women and shod populations. A detailed description of the relevant anatomy, biomechanics, and pathophysiology is found above. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Relevant anatomy and biomechanics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although HV is easily recognized by clinical examination, x-rays may be necessary to determine the presence of articular damage. Neither radiographic nor clinical appearance provides the basis for surgical referral, which is determined by patient pain and disability. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is little evidence that conservative treatments are useful in the treatment of HV. Nevertheless, we suggest patients without debilitating symptoms avail themselves of conservative therapies before being referred for surgery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Possible treatments include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Shoe modification: wide, low-heeled shoes, or specially altered shoes with increased medial pocket for first metatarsophalangeal (MTP) joint to minimize deforming forces",
"     </li>",
"     <li>",
"      Orthoses to improve support and alignment",
"     </li>",
"     <li>",
"      Night splinting to improve toe alignment",
"     </li>",
"     <li>",
"      Stretching",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       mobilization/manipulation",
"      </span>",
"      to maintain joint mobility",
"     </li>",
"     <li>",
"      Medial bunion pads to prevent irritation",
"     </li>",
"     <li>",
"      Ice applied after activity to reduce inflammation",
"     </li>",
"     <li>",
"      Analgesics:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      or NSAIDs (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Conservative management'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest that patients with severe pain or dysfunction and those whose symptoms do not improve under a conservative treatment regimen be referred for surgical repair (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Approximately 150 surgical procedures for the correction of HV deformity have been described. Few prospective, randomized trials evaluating these procedures have been performed. Patients should be referred to a foot surgery specialist with experience repairing HV deformity. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Managing patient expectations about surgery is important. Patients should understand that 10 to 25 degrees of valgus angulation is normal at the MTP joint, and that resolution of postoperative pain and swelling may require several months. Most patients will remain unable to fit into narrower shoes. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Patient satisfaction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/1\">",
"      HARDY RH, CLAPHAM JC. Observations on hallux valgus; based on a controlled series. J Bone Joint Surg Br 1951; 33-B:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/2\">",
"      Piggott, H. The natural history of hallux valgus in adolescence and early adult life. J Bone Joint Surg 1960; 42B:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/3\">",
"      Tanaka Y, Takakura Y, Takaoka T, et al. Radiographic analysis of hallux valgus in women on weightbearing and nonweightbearing. Clin Orthop Relat Res 1997; :186.",
"     </a>",
"    </li>",
"    <li>",
"     Mann R, Coughlin M. Adult hallux valgus. In: Surgery of the Foot and Ankle, Coughlin M, Mann R.  (Eds), Mosby, St. Louis 1999. p.150.",
"    </li>",
"    <li>",
"     Phillips D. Biomechanics in Hallux Valgus and Forefoot Surgery, Churchill Livingstone, New York 1988. p.39.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/6\">",
"      Turan I. Correlation between hallux valgus angle and age. J Foot Surg 1990; 29:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/7\">",
"      Hung LK, Ho YF, Leung PC. Survey of foot deformities among 166 geriatric inpatients. Foot Ankle 1985; 5:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/8\">",
"      HEWITT D, STEWART AM, WEBB JW. The prevalence of foot defects among wartime recruits. Br Med J 1953; 2:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/9\">",
"      CRAIGMILE DA. Incidence, origin, and prevention of certain foot defects. Br Med J 1953; 2:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/10\">",
"      Merrill HE, Frankson J Jr, Tarara EL. Podiatry survey of 1011 nursing home patients in Minnesota. J Am Podiatry Assoc 1967; 57:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/11\">",
"      Elton PJ, Sanderson SP. A chiropodial survey of elderly persons over 65 years in the community. Public Health 1986; 100:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/12\">",
"      Brodie, BS, Rees, CL, Robins, D, Wilson, AF. Wessex feet: a regional foot health survey. Chiropodist 1988; :152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/13\">",
"      Anwar, G. Chiropody need and services in pregnancy: a survey of pregnant women in City and Hackney Health District. Chiropodist 1989; :163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/14\">",
"      Benvenuti F, Ferrucci L, Guralnik JM, et al. Foot pain and disability in older persons: an epidemiologic survey. J Am Geriatr Soc 1995; 43:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/15\">",
"      SHINE IB. INCIDENCE OF HALLUX VALGUS IN A PARTIALLY SHOE-WEARING COMMUNITY. Br Med J 1965; 1:1648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/16\">",
"      Maclennan R. Prevalence of hallux valgus in a neolithic New Guinea population. Lancet 1966; 1:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/17\">",
"      SIM-FOOK L, HODGSON AR. A comparison of foot forms among the non-shoe and shoe-wearing Chinese population. J Bone Joint Surg Am 1958; 40-A:1058.",
"     </a>",
"    </li>",
"    <li>",
"     Wilson DW. Hallux valgus and rigidus. In: The Foot, Helal B, Wilson D.  (Eds), Churchill Livingstone, New York 1988. Vol 1, p.411.",
"    </li>",
"    <li>",
"     Root ML, Orien WP, Weed JH. Forefoot deformity caused by abnormal subtalar joint pronation. In: Normal and Abnormal Functions of the Foot, Clinical Biomechanics, Root ML, Orien WP, Weed JH.  (Eds), Clinical Biomechanics Corporation, Los Angeles 1977. Vol 2, p.376.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/20\">",
"      La Reaux RL, Lee BR. Metatarsus adductus and hallux abducto valgus: their correlation. J Foot Surg 1987; 26:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/21\">",
"      Griffiths TA, Palladino SJ. Metatarsus adductus and selected radiographic measurements of the first ray in normal feet. J Am Podiatr Med Assoc 1992; 82:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/22\">",
"      Faber FW, Kleinrensink GJ, Verhoog MW, et al. Mobility of the first tarsometatarsal joint in relation to hallux valgus deformity: anatomical and biomechanical aspects. Foot Ankle Int 1999; 20:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/23\">",
"      Fritz GR, Prieskorn D. First metatarsocuneiform motion: a radiographic and statistical analysis. Foot Ankle Int 1995; 16:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/24\">",
"      Brahm SM. Shape of the first metatarsal head in hallux rigidus and hallux valgus. J Am Podiatr Med Assoc 1988; 78:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/25\">",
"      Ferrari J, Malone-Lee J. The shape of the metatarsal head as a cause of hallux abductovalgus. Foot Ankle Int 2002; 23:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/26\">",
"      Cralley JC, McGonagle W, Fitch K. The role of adductor hallucis in bunion deformity: Part I. J Am Podiatry Assoc 1976; 66:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/27\">",
"      Bozant JG, Serletic DR, Phillips RD. Tibialis posterior tendon associated with hallux abducto valgus. A preliminary study. J Am Podiatr Med Assoc 1994; 84:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/28\">",
"      Carl A, Ross S, Evanski P, Waugh T. Hypermobility in hallux valgus. Foot Ankle 1988; 8:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/29\">",
"      McNerney JE, Johnston WB. Generalized ligamentous laxity, hallux abducto valgus and the first metatarsocuneiform joint. J Am Podiatry Assoc 1979; 69:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/30\">",
"      Haas C, Kladny B, Lott S, et al. [Progression of foot deformities in rheumatoid arthritis--a radiologic follow-up study over 5 years]. Z Rheumatol 1999; 58:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/31\">",
"      Dimonte P, Light H. Pathomechanics, gait deviations, and treatment of the rheumatoid foot: a clinical report. Phys Ther 1982; 62:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/32\">",
"      Kirkup JR, Vidigal E, Jacoby RK. The hallux and rheumatiod arthritis. Acta Orthop Scand 1977; 48:527.",
"     </a>",
"    </li>",
"    <li>",
"     Jahss M. Disorders of the hallux and first ray. In: Disorders of the Foot and Ankle: Medical and Surgical Management, Jahss M.  (Ed), Saunders and Company, Philadelphia 1991. p.946.",
"    </li>",
"    <li>",
"     Haas M. Radiographic and biomechanical consideratiosn of bunion surgery. In: Textbook of Bunion Surgery, Gerbert J, Sokoloff T.  (Eds), Futura Publishing, New York 1981. p.55.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/35\">",
"      Rosen JS, Grady JF. Neuritic bunion syndrome. J Am Podiatr Med Assoc 1986; 76:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/36\">",
"      Vanore JV, Christensen JC, Kravitz SR, et al. Diagnosis and treatment of first metatarsophalangeal joint disorders. Section 1: Hallux valgus. J Foot Ankle Surg 2003; 42:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/37\">",
"      Ferrari J, Higgins JP, Prior TD. Interventions for treating hallux valgus (abductovalgus) and bunions. Cochrane Database Syst Rev 2004; :CD000964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/38\">",
"      Budiman-Mak E, Conrad KJ, Roach KE, et al. Can Foot Orthoses Prevent Hallux Valgus Deformity in Rheumatoid Arthritis? A Randomized Clinical Trial. J Clin Rheumatol 1995; 1:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/39\">",
"      Torkki M, Malmivaara A, Seitsalo S, et al. Surgery vs orthosis vs watchful waiting for hallux valgus: a randomized controlled trial. JAMA 2001; 285:2474.",
"     </a>",
"    </li>",
"    <li>",
"     Juriansz, A. Conservative treatment of hallux valgus: a randomised controlled clinical trial of a hallux valgus night splint, King's College, University of London, Thesis/Dissertation 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/41\">",
"      Bek, N, Kurklu, B. Comparison of different conservative treatment approaches in patients with hallux valgus. Artroplasti Artroskopik Cerrali 2002; 13:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/42\">",
"      Tehraninasr A, Saeedi H, Forogh B, et al. Effects of insole with toe-separator and night splint on patients with painful hallux valgus: a comparative study. Prosthet Orthot Int 2008; 32:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/43\">",
"      du Plessis M, Zipfel B, Brantingham JW, et al. Manual and manipulative therapy compared to night splint for symptomatic hallux abducto valgus: an exploratory randomised clinical trial. Foot (Edinb) 2011; 21:71.",
"     </a>",
"    </li>",
"    <li>",
"     Brantingham JW, Guiry S, Kretzmann HH, et al. A pilot study of th efficacy of conservative chiropractic protocol using graded mobilization, manipulation and ice in the treatment of symptomatic hallux abductovalgus bunion. Clin Chiro 2005; 8:117. file://www.clinchiropractic.com/article/S1479-2354(05)00047-7/abstract (Accessed on January 31, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/45\">",
"      Khan MT. The podiatric treatment of hallux abducto valgus and its associated condition, bunion, with Tagetes patula. J Pharm Pharmacol 1996; 48:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/46\">",
"      Resch, S, Stenstom, D, Jonsson, K, Reynisson, K. Results after chevron osteotomy and proximal osteotomy for hallux valgus: a prospective, randomised study. The Foot 1993; 3:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/47\">",
"      Klosok JK, Pring DJ, Jessop JH, Maffulli N. Chevron or Wilson metatarsal osteotomy for hallux valgus. A prospective randomised trial. J Bone Joint Surg Br 1993; 75:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/48\">",
"      Sherman KP, Douglas DL, Benson MK. Keller's arthroplasty: is distraction useful? A prospective trial. J Bone Joint Surg Br 1984; 66:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/49\">",
"      O'Doherty DP, Lowrie IG, Magnussen PA, Gregg PJ. The management of the painful first metatarsophalangeal joint in the older patient. Arthrodesis or Keller's arthroplasty? J Bone Joint Surg Br 1990; 72:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/50\">",
"      Faber FW, Mulder PG, Verhaar JA. Role of first ray hypermobility in the outcome of the Hohmann and the Lapidus procedure. A prospective, randomized trial involving one hundred and one feet. J Bone Joint Surg Am 2004; 86-A:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/51\">",
"      Turnbull T, Grange W. A comparison of Keller's arthroplasty and distal metatarsal osteotomy in the treatment of adult hallux valgus. J Bone Joint Surg Br 1986; 68:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/52\">",
"      Deenik A, van Mameren H, de Visser E, et al. Equivalent correction in scarf and chevron osteotomy in moderate and severe hallux valgus: a randomized controlled trial. Foot Ankle Int 2008; 29:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/53\">",
"      Saro C, Andr&eacute;n B, Wildemyr Z, Fell&auml;nder-Tsai L. Outcome after distal metatarsal osteotomy for hallux valgus: a prospective randomized controlled trial of two methods. Foot Ankle Int 2007; 28:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/54\">",
"      Mart&iacute;nez-Nova A, S&aacute;nchez-Rodr&iacute;guez R, G&oacute;mez-Mart&iacute;n B, et al. The effect of adductor tendon transposition in the modified McBride procedure. Foot Ankle Spec 2008; 1:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/55\">",
"      Basile, A, Battaglia, A, Campi, A. Comparison of chevron-Akin osteotomy and distal soft tissue reconstruction-Akin osteotomy for correction of mild hallux valgus. J Foot Ankle Surg 2000; 6:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/56\">",
"      Resch S, Stenstr&ouml;m A, Reynisson K, Jonsson K. Chevron osteotomy for hallux valgus not improved by additional adductor tenotomy. A prospective, randomized study of 84 patients. Acta Orthop Scand 1994; 65:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1960/abstract/57\">",
"      Lee HJ, Chung JW, Chu IT, Kim YC. Comparison of distal chevron osteotomy with and without lateral soft tissue release for the treatment of hallux valgus. Foot Ankle Int 2010; 31:291.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 208 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-89ED0DCEDC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1960=[""].join("\n");
var outline_f1_58_1960=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RELEVANT ANATOMY AND BIOMECHANICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Basic forefoot anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      First ray anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pathophysiology of HV deformity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Associated findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Conservative management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Orthoses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Splinting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1633258\">",
"      - Mobilization and manipulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Patient satisfaction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Arthrodesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Arthroplasty",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Osteotomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Soft tissue procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/208\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/208|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/51/20275\" title=\"diagnostic image 1\">",
"      Hallux abductus xray",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/208|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/7/30835\" title=\"figure 1\">",
"      Foot anatomy lateral view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/40/38530\" title=\"figure 2\">",
"      Foot anatomy medial view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/20/2375\" title=\"figure 3\">",
"      Foot anatomy superior view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/12/33987\" title=\"figure 4\">",
"      Hallux valgus measurement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/57/3990\" title=\"figure 5\">",
"      Hallux valgus anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/208|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/57/913\" title=\"picture 1\">",
"      Night splint",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12614?source=related_link\">",
"      Metatarsal shaft fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/50/29473?source=related_link\">",
"      Patient information: Bunion (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44358?source=related_link\">",
"      Toe fractures in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_58_1961="Musculoskeletal screen 3";
var content_f1_58_1961=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 609px\">",
"   <div class=\"ttl\">",
"    The pGALS musculoskeletal screen (continued)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 589px; height: 715px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     pGALS: pediatric Gait Arms Legs Spine.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Foster, HE, Jandial, S. pGALS - A Screening Examination of the Musculoskeletal System in School-Aged Children. Reports on the Rheumatic Diseases (Series 5), Hands On 15. Arthritis Research Campaign; 2008 June. Copyright &copy;2008 Arthritis Research Campaign.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1961=[""].join("\n");
var outline_f1_58_1961=null;
var title_f1_58_1962="Adequacy of peritoneal dialysis";
var content_f1_58_1962=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Adequacy of peritoneal dialysis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/58/1962/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/58/1962/contributors\">",
"     John M Burkart, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/58/1962/contributors\">",
"     William L Henrich, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/58/1962/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/58/1962/contributors\">",
"     Thomas A Golper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/58/1962/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/58/1962/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/58/1962/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal method to assess the adequacy of peritoneal dialysis (PD) therapies (both continuous ambulatory PD (CAPD) or automated peritoneal dialysis (APD)), as with hemodialysis therapies, is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/1\">",
"     1",
"    </a>",
"    ]. Liberal clinical criteria for adequate dialysis include a feeling of well-being, the absence of uremic symptoms, and reasonable control of biochemical parameters. However, many of these are subjective, and often minimized by the patient. On the other hand, the presence of uremic symptoms (such as nausea, vomiting, or chest pain from pericarditis) or rising BUN and plasma creatinine concentrations provide clear evidence of uremic symptoms or insufficient clearance of uremic toxins. Other methods to quantify the adequacy of dialysis include laboratory measurements of solute clearance using urea or creatinine kinetics.",
"   </p>",
"   <p>",
"    Historical observational studies suggested that more solute clearance would improve patient well being and relative risk of death. As a result, guidelines such as those from the National Kidney Foundation Dialysis Outcomes Quality Initiative (NKF-DOQI) recommended a weekly total solute removal in terms of",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    for CAPD of greater than 2.1 per week [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/2\">",
"     2",
"    </a>",
"    ]. Due in part to increased awareness of the link between adverse outcome and inadequate dialysis, and national guidelines such as the KDOQI guidelines mentioned above, epidemiologic data suggest that the average peritoneal dialysis dose delivered to patients in the United States has increased to a stable level over the early 2000s [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. In 2007, over 93 percent of all patients undergoing CAPD in the United States had a mean weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    of greater than 1.7 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/6\">",
"     6",
"    </a>",
"    ]. Because of this emphasis on achieving higher dialysis doses, transfer to hemodialysis because of inability to achieve the target",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of at least 2.1, was noted to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/7,8\">",
"     7,8",
"    </a>",
"    ], unfortunately, perhaps at times when it was not needed on a clinical basis.",
"   </p>",
"   <p>",
"    These higher solute clearances (weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    &gt;2.1) targets may not have been necessary. Evidence has emerged that lower weekly solute clearances are associated with similar survival rates. In addition, when the dose of dialysis is increased to achieve higher target values, there is always the potential for the introduction of adverse effects associated with efforts to enhance the dose. This may include hernias from the increased intraabdominal pressure due to larger volumes of dialysis solution infusion, patient dissatisfaction because of the increased time needed to perform exchanges, weight gain and other metabolic consequences from higher glucose exposure and absorption, possible systemic toxicity from any components of the PD solution that may be absorbed (glucose degradation products), and a higher cost to society for the additional dialysis solutions. These effects may be minimized with the new weekly solute clearance targets discussed in this topic review.",
"   </p>",
"   <p>",
"    The determinants of and the methods used for the assessment of peritoneal dialysis adequacy will be reviewed here. These methods have largely been confined to estimates of solute clearance, due in part to the correlation between solute clearance and patient outcome. However, it is acknowledged that the signs and symptoms of uremia are related to all the retained solutes and loss of metabolic control that results from loss of renal function. Inadequate ultrafiltration may also contribute to adverse outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/9-12\">",
"     9-12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SOLUTE CLEARANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A BUN level below 100",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (36",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and a plasma creatinine concentration below 18",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1584",
"    <span class=\"nowrap\">",
"     &micro;mol/L)",
"    </span>",
"    were, in the past, considered to represent adequate biochemical treatment in PD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/13\">",
"     13",
"    </a>",
"    ]. Subsequently, calculations of a weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    for urea",
"    <span class=\"nowrap\">",
"     (Kt/Vurea)",
"    </span>",
"    and a weekly creatinine clearance (CCr) were proposed as more objective criteria for adequacy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Kt/Vurea and creatinine clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adequate dialysis was originally defined by some investigators as a weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    exceeding 1.7; lower values were considered inadequate, often being associated with increasing symptoms, hypoalbuminemia (a marker for malnutrition), and a protein catabolic rate below 0.9",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    per day (an index of decreased protein intake that was presumably due to diminished appetite) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/17/277?source=see_link\">",
"     \"Protein catabolic rate in maintenance dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These observations were primarily based upon anecdotal clinical experience and cross-sectional data suggesting that both hypoalbuminemia and lower weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    levels were associated with increased mortality in patients treated with PD (",
"    <a class=\"graphic graphic_figure graphicRef60944 \" href=\"UTD.htm?19/49/20253\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=see_link\">",
"     \"Patient survival and maintenance dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     CANUSA study",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypothesis that a lower weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    level is associated with increased mortality was supported in a prospective, cohort, multicenter observational study in Canada and the United States (CANUSA) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/17\">",
"     17",
"    </a>",
"    ]; this study evaluated the relationship of the adequacy of dialysis and nutritional status to mortality, morbidity, and technique failure. The following results were obtained:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A decrease of 0.1 unit in total (peritoneal and residual renal)",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      was associated with a 5 percent increase in the relative risk of death (",
"      <a class=\"graphic graphic_figure graphicRef51473 \" href=\"UTD.htm?29/57/30622\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A decrease in total (peritoneal and corrected residual renal) weekly creatinine clearance of 5",
"      <span class=\"nowrap\">",
"       L/1.73",
"      </span>",
"      m2 body surface area was associated with a 7 percent increase in the relative risk of death (",
"      <a class=\"graphic graphic_figure graphicRef71413 \" href=\"UTD.htm?37/22/38254\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A decrease in creatinine clearance was associated with an increase in the relative risk of technique failure and incidence of hospitalization.",
"     </li>",
"     <li>",
"      A",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      of 2.1 and a weekly creatinine clearance of 70",
"      <span class=\"nowrap\">",
"       L/1.73",
"      </span>",
"      m2 body surface area were both associated with a 78 percent expected two year survival rate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These predicted survival results were based upon total clearance values and two important assumptions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Total clearance remains constant",
"     </li>",
"     <li>",
"      1 unit of peritoneal clearance equals 1 unit of residual renal clearance",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, in a reanalysis of this study, survival was largely related to residual renal function (which changed over time) and not to peritoneal clearance alone (which did not change) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/18\">",
"     18",
"    </a>",
"    ]. Findings consistent with this observation were reported in some subsequent observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. In a report of nearly 2700 patients, for example, each mL per minute increase in the renal creatinine clearance, but not the clearance obtained with peritoneal dialysis, was associated with a 12 percent reduction in the odds ratio for death [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We therefore recommend measures aimed at preserving residual renal function among peritoneal dialysis patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     ADEMEX and Hong Kong trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subsequent to the CANUSA study, two prospective randomized controlled clinical trials evaluated the relationship of various levels of small solute clearance on the relative risk of death. These trials, referred to as the ADEMEX and Hong Kong studies, support the concept that the minimally acceptable delivered small solute clearance for patients on PD is less than what was previously recommended. These trials are reviewed in this section.",
"   </p>",
"   <p>",
"    The ADEMEX trial was a prospective randomized trial conducted in Mexico that compared two levels of dialysis dose [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/21\">",
"     21",
"    </a>",
"    ]. In this prospective study, 965 patients were randomly assigned to either continuation of their usual dialysis prescription (four daily 2 liter exchanges) or an increase in dose to maintain a creatinine clearance of greater than 60",
"    <span class=\"nowrap\">",
"     liters/week",
"    </span>",
"    per 1.73 m2. Initial clearance values and demographic variables were the same in both groups. Body mass index (BMI) was similar in the two groups (25.3 and 25.8",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    respectively). The intervention was confined to the higher dialysis dose group, with the control group actually being an observational cohort (ie, patients were not randomized to a lower dose of dialysis but rather continued on their pre-study \"standard\" dose of dialysis). As with the HEMO trial, this study did not definitively establish a lower limit of total solute clearance.",
"   </p>",
"   <p>",
"    Patients were followed for a minimum of two years, unless they were transplanted or died. During this period, peritoneal creatinine clearance values and",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    remained the same for the control group (46",
"    <span class=\"nowrap\">",
"     liters/week",
"    </span>",
"    per 1.73 m2 and 1.62, respectively), and by study design, markedly increased in the intervention group (57",
"    <span class=\"nowrap\">",
"     liters/week",
"    </span>",
"    per 1.73 m2 and 2.13, respectively). At study end, there was no difference in overall patient survival between the two groups (68 and 69 percent); these overall mortality rates are similar to those observed in the United States and similar to the two year survival observed in the HEMO trial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6378?source=see_link&amp;anchor=H11#H11\">",
"     \"Kt/V and the adequacy of hemodialysis\", section on 'HEMO study'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 50 percent of patients in each group were anuric. In a subgroup analysis of these patients, there was also no difference in survival between groups assigned to either dose [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/22\">",
"     22",
"    </a>",
"    ]. In addition, there was no difference in quality of life, despite quality of life predicting outcome.",
"   </p>",
"   <p>",
"    In the study from Hong Kong, 320 new CAPD patients were randomly assigned to a target",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of 1.5 to 1.7, 1.7 to 2.0, or greater than 2.0 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/23\">",
"     23",
"    </a>",
"    ]. As with the ADEMEX trial, total solute clearance (residual renal and peritoneal) was measured and targeted. All patients had to have a residual renal",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    of &lt;1.0 to be randomized. Average body mass index was 22",
"    <span class=\"nowrap\">",
"     kg/m2,",
"    </span>",
"    smaller than that of patients in the ADEMEX study. Although there was no difference among the three groups in survival, serum albumin levels, and hospitalization rates, patients assigned to a dialysis dose of less than 1.7 required higher doses of erythropoietin and had more uremic symptoms than those in the other two groups.",
"   </p>",
"   <p>",
"    In contrast to the ADEMEX trial in which the control group continued on the baseline prescription (no intervention), there was an attempt in the Hong Kong trial to maintain total",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    between 1.5 and 1.7. During the study, some patients who were randomized to that dialysis dose actually had their baseline PD prescription decreased. However, separation between groups was not achieved until almost one year into the study; thus, follow-up for patients in the \"lowest randomized dose\" at the target level was only short term. No one was randomized to a dose with a weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    &lt;",
"    <span class=\"nowrap\">",
"     1.5/week.",
"    </span>",
"    Therefore, the \"minimal\" dose of adequate dialysis was not firmly established.",
"   </p>",
"   <p>",
"    A similar lack of survival benefit with increased dialysis has been observed in multiple additional observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/24-27\">",
"     24-27",
"    </a>",
"    ]. In a prospective observational study from the Netherlands, the correlation between peritoneal solute clearance and survival was evaluated among 130 anuric patients undergoing PD, of whom 102 were being administered CAPD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/26\">",
"     26",
"    </a>",
"    ]. A significant increase in the relative risk of death was only associated with very low levels of dialysis: a",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    &lt;1.5 per week and a creatinine clearance &lt;40",
"    <span class=\"nowrap\">",
"     L/week/1.73",
"    </span>",
"    m2.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     2006 K/DOQI guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Findings from ADEMEX, the Hong Kong trial, and other studies provide support for the establishment of a lower delivered weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    in the range of 1.7 or 1.8 per week [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/28\">",
"     28",
"    </a>",
"    ]. The two randomized controlled studies were the principal data used to formulate the recommendations for the 2006",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2006",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    work group recommends the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with residual kidney function (RKF) (arbitrarily considered to be significant if urine volume is &gt;100",
"      <span class=\"nowrap\">",
"       mL/day):",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The minimal delivered dose of small solute clearance should be a total (PD and RKF)",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      of at least",
"      <span class=\"nowrap\">",
"       1.7/week.",
"      </span>",
"      The total solute clearance (PD and RKF) in terms of",
"      <span class=\"nowrap\">",
"       Kt/V",
"      </span>",
"      urea should be measured within the first month of PD and, subsequently, at least once every four months. If used, a 24 hour urine collection for urine volume and solute clearance should be obtained, at a minimum, every 2 months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=see_link\">",
"     \"Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients without RKF (considered insignificant if urine volume is &lt;100",
"      <span class=\"nowrap\">",
"       mL/day):",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The minimal delivered dose of small solute clearance should be a peritoneal",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      of at least",
"      <span class=\"nowrap\">",
"       1.7/week.",
"      </span>",
"      The dose should be measured within the first month of starting dialysis and, subsequently, at least every four months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consistent with this view are the 2005 European Best Practices Guidelines and the 2006 International Society for Peritoneal Dialysis (ISPD)",
"    <span class=\"nowrap\">",
"     Guidelines/Recommendations,",
"    </span>",
"    which suggest a minimum weekly target",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of 1.7 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. We also recommend that the minimal delivered total solute clearance of",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    should be at least",
"    <span class=\"nowrap\">",
"     <strong>",
"      1.7/week",
"     </strong>",
"    </span>",
"    for all patients undergoing peritoneal dialysis",
"   </p>",
"   <p>",
"    There are some cautions that must be mentioned when reviewing the new",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    guidelines. First, in contrast to prior guidelines where a target dose was recommended (so that if delivered dose is less than targeted dose the patient would still be in a safe dose range and unlikely to have severe uremic symptoms), these guidelines recommend a minimal delivered dose stating that everyone should be above this minimum at all times.",
"   </p>",
"   <p>",
"    However, this does not preclude each dialysis center from establishing its own target level to ensure the delivered dose is above the",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    minimal dose. Since the actual delivered dose is frequently below that which is prescribed, the clinician should consider prescribing an optimal dose that, when delivered, provides a dialysis dose above a basic minimal threshold level to practically all patients. In contrast, one could prescribe an adequate target dialysis dose (such as a",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    of",
"    <span class=\"nowrap\">",
"     1.7/week),",
"    </span>",
"    recognizing that the delivered dialysis dose would likely frequently fall below the target level in a subgroup of patients. At our unit, we prescribe a target dose that is sufficiently above the minimum threshold level so that all patients are likely to always receive such minimal values. Our target is a",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of",
"    <span class=\"nowrap\">",
"     1.8/week.",
"    </span>",
"   </p>",
"   <p>",
"    A second caution is that the patients in Mexico and Honk Kong tended to be smaller and in general have lower dietary protein intakes than observed in the United States. It is acknowledged that dialysis adequacy includes more than small solute clearance, with metabolic control also being significant. If a patient is eating significantly more protein than the patients in those two studies, they may need a higher solute clearance rate or dose of dialysis to prevent acidosis and uremic symptoms related to protein metabolism. Although the ADEMEX and Honk Kong studies did not find a spontaneous increase in protein intake in patients randomly assigned to the higher dialysis doses, this does not imply that some patients would not need higher doses of dialysis to maintain metabolic control.",
"   </p>",
"   <p>",
"    Third, if residual renal function is included in total solute clearance measurements, it is important to get follow up values of residual renal clearance every two months. The clinician should be prepared to increase the peritoneal component if there is a decrease in the residual kidney portion. This is especially true if the total solute clearance is only minimally above the minimal threshold and a significant portion of the total is due to residual kidney function. There is marked variability in the measured 24 hour clearance from day to day (perhaps due to difficulty in accurately collecting a 24 hour volume in a patient with advanced chronic kidney disease) and residual renal function is likely to decrease over time, especially if the patient is exposed to any nephrotoxins.",
"   </p>",
"   <p>",
"    Overall, there is a paucity of data to prove that replacing lost residual renal clearance with increased peritoneal clearance will give the predicted results in terms of relative risk of death. Nevertheless, there is a general consensus that such a relationship in part exists and that total small solute clearance must be kept above a certain minimum amount to optimize outcomes, patient well being and longevity. In fact, in the Hong Kong and the ADEMEX study, the peritoneal prescription was altered as residual kidney function decreased to maintain target weekly total solute clearance goals.",
"   </p>",
"   <p>",
"    As noted above, historically, most investigators agreed that either urea or creatinine kinetics could be used as a yardstick for adequate PD. As a result, it was recommended that calculation of both the weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    and the peritoneal creatinine clearance should be used to assess dialysis adequacy. It was therefore proposed that adequate dialysis required either a total weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    of &gt;2.0,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a total weekly creatinine clearance of at least 60 L per week per 1.73 m2 body surface area [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/15,17,32,33\">",
"     15,17,32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, the 2006 NKF-KDOQI guidelines recommend using",
"    <strong>",
"     only",
"    </strong>",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    urea as the \"yardstick\" for dialysis dose and see no additional benefit to using both",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    and creatinine clearance to monitor dialysis dose. They therefore recommend that a total solute clearance target should only be in terms of",
"    <span class=\"nowrap\">",
"     Kt/Vurea.",
"    </span>",
"    However, in the text and in the clinical practice recommendation section, it is noted that knowledge of weekly creatinine clearance may be helpful for other reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      24 hour creatinine excretion is a surrogate for creatinine generation and hence muscle mass. A decreasing value would suggest muscle loss either as a result of malnutrition, disuse, surgical amputation, or aging. Sequential measurements may be an additional parameter to monitor. (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=see_link\">",
"       \"Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Optimizing creatinine clearance would also promote increased phosphate removal, since phosphate clearance tends to parallel that of creatinine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Maneuvers that increase urea clearance may not necessarily result in an increase in creatinine clearance and other molecules of the same or larger molecular weight. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26868?source=see_link\">",
"     \"Why Kt/V and creatinine clearance may not correlate in continuous peritoneal dialysis\"",
"    </a>",
"    .) In general, if one wants to monitor both, we recommend that threshold",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    values should be met when there are discrepant values.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Automated peritoneal dialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no prospective randomized trials that have looked at relative risk of death in relationship to dose in automated peritoneal dialysis (APD) patients",
"    <strong>",
"     only",
"    </strong>",
"    . Prior guidelines for an increase in dose were opinion-based and were extrapolations from",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    studies in hemodialysis patients.",
"   </p>",
"   <p>",
"    There is a current consensus that this previous extrapolation is not indicated. This is because mortality outcomes in the HEMO trial and the ADEMEX trial were similar, approximately 70 percent survival at two years, despite markedly differences in attained",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    in the two trials. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6378?source=see_link\">",
"     \"Kt/V and the adequacy of hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We therefore agree with the 2006",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    work group that higher targets are not required with APD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/29\">",
"     29",
"    </a>",
"    ]. We suggest that the minimal dose of",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    should be",
"    <span class=\"nowrap\">",
"     1.7/week",
"    </span>",
"    for those undergoing APD. Although not a part of the NKF-DOQI 2006 guidelines, in order to minimize lack of clearance of larger solutes, the 2006 ISPD guidelines also suggest that in addition to weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    targets, given the variable relationship between urea and creatinine clearance, one should consider an additional CCr target of 45",
"    <span class=\"nowrap\">",
"     L/week",
"    </span>",
"    per 1.73 m2 for APD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another caveat for APD is that, once the patient is anuric or with minimal urine volume, the patient should undergo 24",
"    <span class=\"nowrap\">",
"     hours/day",
"    </span>",
"    of PD to optimize middle molecular weight solute clearance, as randomized trials have only evaluated patients undergoing 24",
"    <span class=\"nowrap\">",
"     hours/day",
"    </span>",
"    of PD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Peritoneal membrane transport",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although solute clearance is a significant controllable factor underlying mortality in all dialysis patients, survival among PD patients is also due to a complex interplay among other characteristics. These include, but are not limited to, age, comorbid conditions, presence of diabetes, country in which patient is getting their dialysis, adherence to the prescription, control of other ESRD related parameters such as blood pressure, calcium-phosphate metabolism, and anemia. Historical observational data suggested that survival on PD was also related to individual peritoneal membrane transport characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/34\">",
"     34",
"    </a>",
"    ]. However, more contemporary data do not support those observational findings, and most investigators feel that there is no survival advantage based on transport type if PD is properly prescribed [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=see_link\">",
"     \"Patient survival and maintenance dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The historical observation on survival and peritoneal transport was first evaluated using the Cox proportional hazards method in a follow-up evaluation of the cohort enrolled in the CANUSA prospective study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/37\">",
"     37",
"    </a>",
"    ]. Increased peritoneal transport was associated with significantly lower survival rates:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At two years, patient survival probabilities were 91, 80, 72, and 71 percent for low, low average, high average, and high transporters, respectively (p = 0.11).",
"     </li>",
"     <li>",
"      When creatinine clearance or",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      were utilized as estimates of dialysis adequacy, the relative risk of death was 1.0, 1.6, 2.3, and 2.0 for the different transport categories.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, after controlling for delivered dose in historic cohorts, low and low average transporters had higher survival rates than high average and high transporters, suggesting that subsets of patients may not require the same level of dialysis adequacy to achieve adequate outcomes. This is particularly important because low and low average transporters may be unable to exceed certain threshold creatinine clearance levels with any currently reasonable dialysis prescription.",
"   </p>",
"   <p>",
"    However, transport type did not influence outcome in the ADEMEX study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/21\">",
"     21",
"    </a>",
"    ]. Furthermore, three contemporary studies also suggest that transport status does not predict survival [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/36,38,39\">",
"     36,38,39",
"    </a>",
"    ]. The first is a retrospective observational cohort study from the United Kingdom [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/39\">",
"     39",
"    </a>",
"    ]. In this analysis, vintage predicted the effect of transport status on survival. Among 320 patients who started PD between 1990 to 1997, there was a higher risk of death among those with higher transport status. However, among 300 patients who started PD between 1998 and 2005, transport status did not predict risk of death. In a subsequent observational cohort study from Canada, transport status was also not predictive of survival [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/36\">",
"     36",
"    </a>",
"    ]. Similar results were found in an ANZDATA analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, individualizing the patients' prescription as related to transport type may not affect survival, if the transport characteristics are not related to comorbidities. However, the prescription should be adjusted according to transport type to minimize glucose and fluid absorption and optimize fluid and solute removal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Peak BUN as determinant of well-being",
"    </span>",
"    &nbsp;&mdash;&nbsp;A minimum weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of 1.7 in CAPD is well below the value achieved with hemodialysis. As an example, the minimum recommended",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    for each hemodialysis is 1.2 which, in a typical patient dialyzed three times per week, represents a weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of 3.6. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6378?source=see_link\">",
"     \"Kt/V and the adequacy of hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, CAPD patients do as well clinically as those undergoing hemodialysis despite the lower",
"    <span class=\"nowrap\">",
"     Kt/Vurea.",
"    </span>",
"    This was best shown in the equivalent mortality at two years in the HEMO and ADEMEX trials despite markedly differences in attained",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    in the two trials. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6378?source=see_link\">",
"     \"Kt/V and the adequacy of hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One explanation for this seeming paradox is that the BUN may not be an optimal index of the retention of uremic toxins and that the more effective clearance of larger \"middle molecules\" with CAPD is responsible for the similar outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/24/37258?source=see_link\">",
"     \"Uremic toxins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Perhaps more important is that the likelihood of developing early uremic symptoms, such as decreased appetite, may be related to the peak plasma value of urea and other small uremic toxins rather than the average value. The BUN rises between hemodialyses and then falls dramatically during dialysis; as a result, a higher net",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    with hemodialysis is required to produce a peak predialysis BUN that is equivalent to the steady state level seen with continuous peritoneal dialysis. The similarity in peak values may explain the similarity in patient well-being despite the much lower weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    with CAPD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/15,40\">",
"     15,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CALCULATION OF SOLUTE CLEARANCE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Weekly Kt/Vurea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    in continuous PD patients can be estimated from the following parameters: the daily peritoneal urea clearance (Kt) is the sum of the product of all drain volumes (peritoneal and residual kidney) and the ratio of the urea concentration in the pooled drained dialysate or urine to that in the plasma",
"    <span class=\"nowrap\">",
"     (D/P",
"    </span>",
"    urea). The volume of distribution of urea (V) is estimated to be equal to body water.",
"   </p>",
"   <p>",
"    As an example, suppose a 70 kg man on CAPD has a drain volume of 10.5",
"    <span class=\"nowrap\">",
"     L/day,",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     D/P",
"    </span>",
"    urea of 0.95; thus, the Kt is equal to 10 L (10.5 x 0.95). The urea volume of distribution (V) is roughly equal to 42 L (60 percent of lean body weight in men, 55 percent in women). As a result:",
"   </p>",
"   <p>",
"    Daily",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    = 10 &divide; 42 = 0.24",
"   </p>",
"   <p>",
"    The weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    is equal to this value multiplied by 7:",
"   </p>",
"   <p>",
"    Weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    = 0.24 x 7 = 1.68",
"   </p>",
"   <p>",
"    This value probably reflects inadequate dialysis. This representative calculation illustrates that an adequate solute clearance goal in terms of",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    is often difficult if not impossible to attain with the historical \"standard\" dialysis prescription of 2.0 L four times per day, particularly among larger anuric patients with low and low average transport characteristics.",
"   </p>",
"   <p>",
"    Patients with a low delivered",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    who appear to have a dialysis prescription that would be predicted to result in an adequate dose of dialysis should be evaluated for the source of the problem. Possible causes include lack of adherence to the dialysis prescription, actual dwell times that are different from those that are prescribed, a change in peritoneal transport type, loss of residual kidney function, incomplete drain, and a hypercatabolic state. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5623?source=see_link\">",
"     \"Peritoneal equilibration test\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23337?source=see_link\">",
"     \"Problems with solute clearance and ultrafiltration in continuous peritoneal dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    &nbsp;Adjustment for body size &mdash; To standardize dosing targets, the patients Kt for urea has historically been normalized by the patients&rsquo; volume of distribution for urea or V. The formula used to estimate V becomes less accurate the more disparate the persons actual weight is (obese or malnourished patients) from his or her ideal weight.",
"   </p>",
"   <p>",
"    Marked differences in the calculation of",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    can be seen depending upon the equation and the weight (ideal or actual) used to estimate V [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. As a result, very large patients may occasionally appear underdialyzed (measured",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    is low) despite doing clinically well, because of problems associated with assuming a fixed percentage of body weight for the volume of distribution (V) of urea.",
"   </p>",
"   <p>",
"    These differences are also significant when assessing the volume of distribution in severely malnourished individuals. In the setting of an unchanging Kt, the measured",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    in a patient losing weight would actually appear to increase at a time that the prescription was not changing. If the initial cause of the weight loss was suboptimal solute clearance, the measured",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    using the lower actual weight would be misleading.",
"   </p>",
"   <p>",
"    The original National Kidney Foundation Dialysis Outcome Quality Initiatives (NKF-DOQI) guidelines recommended the use of the patient's actual weight; however, in malnourished patients, they recommended adjusting their target weight by the ratio of",
"    <span class=\"nowrap\">",
"     ideal/actual",
"    </span>",
"    weight (essentially the same concept as using the ideal weight) to promote anabolism and enough solute clearance to equal the metabolic needs of an increased protein intake. The original guidelines were unclear for patients significantly above their ideal weight (obese patients). We agree with the 2006 NKF-KDOQI guidelines that recommend using ideal body weight in all cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Residual renal function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The value for total weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    may include the contribution of residual kidney function which, for urea kinetics, can be estimated from a 24-hour urine collection for urea clearance. In cases where the patient has significant residual renal function (arbitrarily defined as a residual kidney volume of greater than 100",
"    <span class=\"nowrap\">",
"     mL/day",
"    </span>",
"    in the 2006 NKF-KDOQI guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/29\">",
"     29",
"    </a>",
"    ]), both the peritoneal and the residual renal components of solute clearance are used in the calculation of total solute clearance.",
"   </p>",
"   <p>",
"    Even relatively small residual urea clearances may contribute substantially to overall clearance among patients undergoing PD. As an example, if the remaining urea clearance is 2",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    in a 70 kg patient, the total residual",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    would be approximately 0.4 units per week (weekly urea clearance of 17 L divided by total body water of 40 L). In such a patient, if the total weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    was 1.7, then the residual clearance would constitute a substantial portion (about 24 percent) of the weekly targeted",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    <span class=\"nowrap\">",
"     (0.4/1.7).",
"    </span>",
"    In these cases, failure to account for the loss of residual renal function over time by increasing the peritoneal component to compensate for the loss, could lead to signs of underdialysis even though there has been no decline in the peritoneal dialysis efficiency (",
"    <a class=\"graphic graphic_figure graphicRef71878 \" href=\"UTD.htm?43/39/44670\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/16,43,44\">",
"     16,43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A dialysis center may elect to ignore residual kidney function in calculating a person's total solute clearance, delivering at least the minimal recommended total solute clearance by peritoneal dialysis alone right from the initiation of dialysis. In this case, the residual kidney function would be of additional benefit. However, if the patient had a significant amount of residual kidney function, this approach may make the peritoneal prescription more demanding or time consuming than it would clinically need to be.",
"   </p>",
"   <p>",
"    Patients with a significant amount of residual renal solute clearance may initially be treated with intermittent peritoneal dialysis (such as nightly cycler peritoneal dialysis with a dry day). This may allow one to prescribe less demanding and intrusive regimens, while still providing adequate overall clearances. Using kinetic modeling, one study found that a weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of 2.0 could be maintained for approximately 1.5 years by using only one or two nightly exchanges in the patient with significant residual function [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/45\">",
"     45",
"    </a>",
"    ]. This would be even easier to achieve with the new minimal total solute clearance recommendations of a weekly total",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    of &gt; 1.7. In this setting, when residual kidney function is a significant portion of total solute clearance, the total solute clearance (peritoneal and residual kidney function) needs to be closely monitored and the delivered dose kept above the minimal at all times. The current",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    guidelines recommend that residual renal clearance should be monitored every other month.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Peritoneal creatinine clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calculation of the peritoneal creatinine clearance (CCr) is similar to that for the",
"    <span class=\"nowrap\">",
"     Kt/Vurea:",
"    </span>",
"    mean daily drain volume times the",
"    <span class=\"nowrap\">",
"     D/P",
"    </span>",
"    creatinine times seven days per week. Again, the total creatinine clearance is due to both peritoneal and residual kidney clearance. When calculating the contribution of residual kidney function, it is recommended that the glomerular filtration rate be estimated from the sum of the urea and creatinine clearances divided by two; this correction accounts for the overestimation of GFR induced by creatinine secretion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35190?source=see_link\">",
"     \"Calculation of the creatinine clearance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    National guidelines from the United States, Canada, and Europe no longer recommend the use of creatinine clearance as the surrogate solute for \"dialysis adequacy.\" However, it is acknowledged that one could continue to monitor 24 hour dialysate and urine creatinine removal because it is an estimation of muscle mass and creatinine clearance mirrors phosphate clearance in PD. (See",
"    <a class=\"local\" href=\"#H6\">",
"     '2006 K/DOQI guidelines'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Differences between small and middle molecular weight solute clearances",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are differences between the clearance of small and middle or large molecular weight solutes with peritoneal dialysis and residual kidney function. As you increase the number of",
"    <span class=\"nowrap\">",
"     exchanges/day,",
"    </span>",
"    instilled",
"    <span class=\"nowrap\">",
"     volume/exchange",
"    </span>",
"    or length of a dwell, one may increase small solute clearance but not necessarily increase middle molecular weight clearances. The following is a brief review of this subject.",
"   </p>",
"   <p>",
"    The ability to attain higher CCr values with a change in the peritoneal prescription is particularly affected by transporter status. Anuric low and low average transporters are much less likely to achieve a weekly CCr value of 60",
"    <span class=\"nowrap\">",
"     L/1.73m2",
"    </span>",
"    when adhering to any reasonably practical dialysis prescription. Kinetic modeling, confirmed by clinical experience, predicts that the average anuric patient with a peritoneal",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of 2.0 has a CCr of only 53 to 55",
"    <span class=\"nowrap\">",
"     L/week",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. This was one reason for the lower minimal creatinine clearance target values in patients who have low or low average peritoneal membrane transport characteristics in the 2000 revision of the Canadian and NKF-KDOQI guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During a long dwell, diffusive transport tends to stop because equilibrium between dialysis and plasma has been reached. The dwell time needed to reach equilibrium varies based on the patient's peritoneal membrane transport characteristics and the molecular weight of the solute in question. For instance, urea will reach equilibrium faster than creatinine which will equilibrate faster than beta 2 microglobulin. The daytime dwell for CCPD (14 to 15 hours) tends to be longer than the nighttime dwell (9 to 10 hours) for CAPD. While the nighttime exchanges of CCPD are relatively shorter than the daytime exchanges in CAPD. Therefore, with the same weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    urea, low and low average transporters may have lower creatinine clearances on cycler therapies than high and high average transport patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     FLUID BALANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between excessive body fluid and enhanced mortality may also exist among patients undergoing peritoneal dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/10,11,51\">",
"     10,11,51",
"    </a>",
"    ]. Although a low",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    and hypoalbuminemia appear to directly correlate with lower overall survival, these factors are not totally independent of fluid volume:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <span class=\"nowrap\">",
"       Kt/Vurea,",
"      </span>",
"      by definition, correlates inversely with volume; a low",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      may therefore represent an excess of total body fluid as well as inadequate solute clearance [",
"      <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Excess hydration can significantly lower serum albumin concentrations by dilution [",
"      <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/26,52-54\">",
"       26,52-54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As a result, the correlation between poor survival and a low",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    or serum albumin concentration may actually be due in part to excess body fluid volume. In a prospective study from the Netherlands, for example, a significant increase in the relative risk of death was associated with decreased clearance among 130 anuric patients undergoing PD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/26\">",
"     26",
"    </a>",
"    ]. In addition, since inadequate ultrafiltration is common in high transport patients, the relatively higher mortality historically observed among these patients could be due to increased hydration [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/10,11,26\">",
"     10,11,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, these correlations are only indirect. Controlled studies of UF volume dialysis dose in rapid transporters and low transporters are needed to properly assess the relative contribution of excess intravascular volume versus transport status to survival. Observational data where patients tend to use APD and some are also using alternative dialysis fluids, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/36/44612?source=see_link\">",
"     icodextrin",
"    </a>",
"    , fail to report a relationship between transport status and risk of death [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Greater fluid removal (peritoneal and kidney) has also been found to be a favorable predictor of improved relative risk of death in observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the interpretation of this finding remains unclear. The greater need for fluid removal may be a surrogate for well being and increased intake, convective clearance of middle molecules,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/12,55,56\">",
"     12,55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2005 European Best Practices Guidelines have published recommendations concerning ultrafiltration goals. They suggested that, in anuric patients, the minimum target value is 1.0",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2006 NKF-KDOQI guidelines have acknowledged the importance of blood pressure control and maintenance of euvolemia in reducing the risk of death in peritoneal dialysis patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/29\">",
"     29",
"    </a>",
"    ]. These guidelines stress that one should achieve euvolemia and optimal blood pressure control, and address possible ways to achieve these goals. However, they do not recommend a minimal daily ultrafiltration volume amount.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The accurate recognition of fluid overload in patients treated with chronic PD can be difficult, particularly among those without obvious symptoms or signs of an excess of total body fluid (eg, peripheral edema, elevated jugular venous pressure, and basilar rales). A more subtle degree of fluid overload may be indicated by the presence of hypertension alone.",
"   </p>",
"   <p>",
"    Among such patients, a successive increase in ultrafiltration to attain a normal blood pressure without reliance upon medications is one method to attain adequate fluid balance [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/57\">",
"     57",
"    </a>",
"    ]. Unfortunately, an accurate noninvasive method to regularly assess total body water in the normotensive patient with lesser degrees of fluid excess is not yet available [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with evidence of fluid overload should be evaluated and, if indicated, the peritoneal dialysis prescription changed. Not all causes of volume overload are the result of peritoneal membrane failure. More often it is due to changes in dietary habits, loss of residual renal function, or mismatch of peritoneal prescription to the patients peritoneal membrane transport characteristics.",
"   </p>",
"   <p>",
"    Interventions that one may consider to improve volume status include but are not limited to the following: dietary sodium restriction; addition of loop diuretics if the patient has significant residual kidney volume; change in peritoneal prescription with special attention to ultrafiltration profile of the long dwell;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    consideration of using alternative osmotic agents. Why this occurs and how it can be treated are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23337?source=see_link\">",
"     \"Problems with solute clearance and ultrafiltration in continuous peritoneal dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PATIENT COMPLIANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The above recommendations assume that the patient is compliant with the dialysis prescription. Unfortunately, this is often not the case. One report, for example, found that 26 percent of stable CAPD patients were not compliant with the recommended regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/59\">",
"     59",
"    </a>",
"    ]; this figure was based upon the assumption that a value greater than one for the ratio of measured to predicted creatinine generation was due to noncompliance. However, an elevation in this ratio is a poor predictor of compliance with the PD prescription [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/60-63\">",
"     60-63",
"    </a>",
"    ]. Despite the lack of easy documentation of noncompliance in PD, this remains an important issue, since as many as 11 percent of patients who switch to hemodialysis do so because of noncompliance.",
"   </p>",
"   <p>",
"    An important influence upon compliance is the number of exchanges per day, with an increased number having an adverse impact upon the quality of life. Compliance may therefore be problematic among those in whom an increased number of exchanges is prescribed to obtain the recommended dialysis dose. To minimize the burden early in the course of renal replacement therapy if one is targeting total solute clearance (residual kidney and peritoneal) as described above, one may only need nightly peritoneal exchanges to achieve the minimal total solute clearance goal. Over time, as residual kidney function continues to decline, this can be replaced by more peritoneal clearance.",
"   </p>",
"   <p>",
"    To encourage compliance, an alternative strategy is to utilize larger exchange volumes. Although many patients are reluctant to use increased volumes because of the fear of abdominal discomfort, this concern appears to be unfounded. This was illustrated in a blinded study in which 15 of 20 patients (75 percent) were unable to distinguish among 2, 2.5, and 3 liter exchange volumes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/58/1962/abstract/64\">",
"     64",
"    </a>",
"    ]. In addition, discomfort was not more common with the 3 liter exchange than with lesser exchange volumes, and increasing exchange volumes was significantly associated with increasing clearances of both creatinine and urea. Although the standard available dialysate sizes are in 500 ml increments, (ie, 1.5, 2.0, 2.5, and 3.0 L bags) one does not need to increase the instilled volume by 500 mL increments: smaller increases in volume may easily be done with APD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/43/16051?source=see_link\">",
"       \"Patient information: Peritoneal dialysis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/10/14501?source=see_link\">",
"       \"Patient information: Peritoneal dialysis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Minimal total solute clearance target values",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on the data previously presented and other findings, minimal weekly total target clearance values in terms of",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    urea and creatinine clearance have been published over the last several years by United States and international societies. There is a general consensus that the previously recommended target weekly dialysis doses are not needed for most patients, which may have unnecessarily resulted in patients transferred to hemodialysis because of perceived inadequate dialysis with PD. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Solute clearance'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The ADEMEX study and Hong Kong trial results have shown that for a population as a whole, using standard peritoneal dialysis regimens, attempts to maintain the previously recommended solute clearance goals are not necessary. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'ADEMEX and Hong Kong trials'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Therefore, the 2006 NKF-KDOQI guidelines revised the minimal delivered total solute clearance goals. The 2006",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    work group recommend the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with residual kidney function (RKF) (considered to be significant if urine volume is &gt;100",
"      <span class=\"nowrap\">",
"       mL/day),",
"      </span>",
"      the minimal \"delivered\" dose of small solute clearance should be a total (PD and RKF)",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      of at least",
"      <span class=\"nowrap\">",
"       1.7/week.",
"      </span>",
"     </li>",
"     <li>",
"      For patients without RKF (considered insignificant if urine volume is &lt;100",
"      <span class=\"nowrap\">",
"       mL/day),",
"      </span>",
"      the minimal \"delivered\" dose of small solute clearance should be a peritoneal",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      of at least",
"      <span class=\"nowrap\">",
"       1.7/week",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"local\" href=\"#H6\">",
"     '2006 K/DOQI guidelines'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Consistent with this view is the 2005 European Best Practices Guidelines that suggest a minimum weekly target",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of 1.7.",
"   </p>",
"   <p>",
"    We recommend that the minimal delivered total solute clearance of",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    should be at least",
"    <span class=\"nowrap\">",
"     <strong>",
"      1.7/week",
"     </strong>",
"    </span>",
"    for patients undergoing continuous ambulatory peritoneal dialysis (",
"    <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"     Grade 1B",
"    </a>",
"    ). We also recommend measures aimed at preserving residual renal function among peritoneal dialysis patients (",
"    <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"     Grade 1B",
"    </a>",
"    ). Our specific recommendations with evidence grade for patients undergoing APD is found below.",
"   </p>",
"   <p>",
"    The minimal delivered total solute clearances recommended in the new guidelines are correct for a population based on current evidence. However, these are minimal recommended doses for a population and individual patients may require more dialysis. Patients should therefore be closely monitored, with the possibility of prescribing more dialysis if the clinical situation warrants a higher prescribed dose.",
"   </p>",
"   <p>",
"    We also feel it is important to remind the reader of a few caveats. The prospective randomized trials that were used to formulate the new guidelines were conducted in short term studies in Mexico and Hong Kong. These populations are different from the typical patient in the United States. Protein intake, size, effect of ethnicity on the therapy, compliance, and severity of comorbidities may vary among these populations.",
"   </p>",
"   <p>",
"    As a result, individuals may need relatively higher solute clearances than those recommended for the peritoneal dialysis population as a whole. A requirement for higher values may be most applicable to some patients in the United States, a country in which higher adequacy goals may be particularly necessary for a relatively older and sicker PD population. In addition, higher values may be necessary in those eating relatively more protein who may have a metabolic need for relatively higher small solute removal rates.",
"   </p>",
"   <p>",
"    In our unit in the United States, we prescribe target doses that are sufficiently above the minimum threshold levels to help ensure that the minimum level of dialysis dose has been delivered to all patients. We aim for a target",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    of",
"    <span class=\"nowrap\">",
"     1.8/week.",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Automated peritoneal dialysis &mdash; There are no prospective randomized trials that have looked at relative risk of death in relationship to dose in automated peritoneal dialysis (APD) patients. We agree with the 2006",
"      <span class=\"nowrap\">",
"       K/DOQI",
"      </span>",
"      work group who felt that the higher targets previously recommended are not required with APD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We suggest that the minimal dose of",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    should be",
"    <span class=\"nowrap\">",
"     1.7/week",
"    </span>",
"    for those undergoing APD (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ). However, once the APD patient is anuric or with minimal urine volume, the patient should undergo 24",
"    <span class=\"nowrap\">",
"     hours/day",
"    </span>",
"    of PD to optimize middle molecular weight solute clearance. This is because randomized trials have only evaluated patients undergoing 24",
"    <span class=\"nowrap\">",
"     hours/day",
"    </span>",
"    of PD. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Automated peritoneal dialysis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Calculation of solute clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    in continuous PD patients can be estimated from the following parameters: the daily peritoneal urea clearance (Kt) is the sum of the product of all drain volumes (peritoneal and residual kidney) and the ratio of the urea concentration in the pooled drained dialysate or urine to that in the plasma",
"    <span class=\"nowrap\">",
"     (D/P",
"    </span>",
"    urea). In cases where the patient has significant residual renal function (arbitrarily defined as a residual kidney volume of greater than 100",
"    <span class=\"nowrap\">",
"     mL/day),",
"    </span>",
"    both the peritoneal and the residual renal components of solute clearance are used in the calculation of total solute clearance. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Calculation of solute clearance'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Fluid balance",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between excessive body fluid and enhanced mortality may exist among patients undergoing peritoneal dialysis. Patients with evidence of fluid overload should be evaluated and, if indicated, the peritoneal dialysis prescription changed.",
"   </p>",
"   <p>",
"    Interventions to improve volume status may include: dietary sodium restriction; addition of loop diuretics if the patient has significant residual kidney volume;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    change in peritoneal prescription with special attention to ultrafiltration profile of the long dwell or consideration of using alternative osmotic agents. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Fluid balance'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/1\">",
"      Chatoth DK, Golper TA, Gokal R. Morbidity and mortality in redefining adequacy of peritoneal dialysis: a step beyond the National Kidney Foundation Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1999; 33:617.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Renal Data System. USRDS 1995 Annual Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/3\">",
"      Frankenfield DL, Prowant BF, Flanigan MJ, et al. Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup. Kidney Int 1999; 55:1998.",
"     </a>",
"    </li>",
"    <li>",
"     US Renal Data System, USRDS 1999 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD, August 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/5\">",
"      US Renal Data System, USRDS 2002 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease. Am J Kidney Dis 2003; 41(Suppl 2):S91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/6\">",
"      US Renal Data System, USRDS 2009 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease. Am J Kidney Dis 2010; 55(Suppl 1):S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/7\">",
"      Gokal R, Jakubowski C, King J, et al. Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. Lancet 1987; 2:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/8\">",
"      Oreopoulos DG. The optimization of continuous ambulatory peritoneal dialysis. Kidney Int 1999; 55:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/9\">",
"      Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int Suppl 1993; 40:S106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/10\">",
"      Blake PG. What is the problem with high transporters? Perit Dial Int 1997; 17:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/11\">",
"      Coles GA. Have we underestimated the importance of fluid balance for the survival of PD patients? Perit Dial Int 1997; 17:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/12\">",
"      Brown EA, Davies SJ, Rutherford P, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14:2948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/13\">",
"      Oreopoulos, DG. Criteria for adequacy of peritoneal dialysis. Perit Dial Bull 1983; 3:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/14\">",
"      Teehan BP, Schleifer CR, Brown J. Adequacy of continuous ambulatory peritoneal dialysis: morbidity and mortality in chronic peritoneal dialysis. Am J Kidney Dis 1994; 24:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/15\">",
"      Keshaviah P. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int Suppl 1993; 40:S28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/16\">",
"      Nolph, KD. Quantitating peritoneal dialysis delivery: A required standard of care. Semin Dial 1991; 4:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/17\">",
"      Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/18\">",
"      Bargman JM, Thorpe KE, Churchill DN, CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12:2158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/19\">",
"      Diaz-Buxo JA, Lowrie EG, Lew NL, et al. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 1999; 33:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/20\">",
"      Termorshuizen F, Korevaar JC, Dekker FW, et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2. Am J Kidney Dis 2003; 41:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/21\">",
"      Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/22\">",
"      Paniagua R, Amato D, Vonesh E, et al. Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial. Kidney Int 2005; 67:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/23\">",
"      Lo WK, Ho YW, Li CS, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/24\">",
"      Szeto CC, Wong TY, Chow KM, et al. Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients. Perit Dial Int 2004; 24:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/25\">",
"      Lo WK, Lui SL, Chan TM, et al. Minimal and optimal peritoneal Kt/V targets: results of an anuric peritoneal dialysis patient's survival analysis. Kidney Int 2005; 67:2032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/26\">",
"      Jansen MA, Termorshuizen F, Korevaar JC, et al. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005; 68:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/27\">",
"      Lam MF, Tang C, Wong AK, et al. ASPD: A prospective study of adequacy in Asian patients on long term, small volume, continuous ambulatory peritoneal dialysis. Perit Dial Int 2006; 26:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/28\">",
"      Moran J, Correa-Rotter R. Revisiting the peritoneal dialysis dose. Semin Dial 2006; 19:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/29\">",
"      K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 2006; 47(Suppl 4):S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/30\">",
"      European Best Practice Guidelines for peritoneal dialysis. Nephrol Dial Transplant 2005; 20(Suppl 9):1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/31\">",
"      Lo WK, Bargman JM, Burkart J, et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 2006; 26:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/32\">",
"      Brandes JC, Piering WF, Beres JA, et al. Clinical outcome of continuous ambulatory peritoneal dialysis predicted by urea and creatinine kinetics. J Am Soc Nephrol 1992; 2:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/33\">",
"      Twardowski ZJ. PET--a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial 1990; 6:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/34\">",
"      Brimble KS, Walker M, Margetts PJ, et al. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17:2591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/35\">",
"      Davies, SJ. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kid Int 2006; 70:S76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/36\">",
"      Yang X, Fang W, Bargman JM, Oreopoulos DG. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis. Perit Dial Int 2008; 28:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/37\">",
"      Churchill DN, Thorpe KE, Nolph KD, et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/38\">",
"      Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006; 17:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/39\">",
"      Davies SJ. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int Suppl 2006; :S76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/40\">",
"      Nolph KD. What's new in peritoneal dialysis--an overview. Kidney Int Suppl 1992; 38:S148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/41\">",
"      Tzamaloukas AH, Murata GH, Malhotra D, et al. Urea kinetic modeling in continuous peritoneal dialysis patients. Effect of body composition on the methods for estimating urea volume of distribution. ASAIO J 1993; 39:M359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/42\">",
"      Tzamaloukas AH, Malhotra D, Murata GH. Indicators of body size in peritoneal dialysis: their relation to urea and creatinine clearances. Perit Dial Int 1998; 18:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/43\">",
"      Lameire NH, Vanholder R, Veyt D, et al. A longitudinal, five year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992; 42:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/44\">",
"      Lameire N, Van Biesen W. The impact of residual renal function on the adequacy of peritoneal dialysis. Perit Dial Int 1997; 17 Suppl 2:S102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/45\">",
"      Keshaviah PR, Emerson PF, Nolph KD. Timely initiation of dialysis: a urea kinetic approach. Am J Kidney Dis 1999; 33:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/46\">",
"      Twardowski ZJ. Relationships between creatinine clearances and Kt/V in peritoneal dialysis patients: a critique of the DOQI document. Dialysis Outcome Quality Initiative, National Kidney Foundation. Perit Dial Int 1998; 18:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/47\">",
"      Meyer, KV, Venkataraman, V, Twardowski, ZJ. Creatine kinetics in peritoneal dialysis. Semin Dial 1998; 11:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/48\">",
"      Blake P, Burkart JM, Churchill DN, et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/49\">",
"      Clinical Practice Guidelines of the Canadian Society of Nephrology for the Treatment of Patients with Chronic Renal Failure. J Am Soc Nephrol 1999; 10:S13.",
"     </a>",
"    </li>",
"    <li>",
"     The Renal Association and Royal College of Physicians of London. Treatment of adult patients with renal failure: Recommended standards and audit measures. Royal College of Physicians, London 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/51\">",
"      Chung SH, Heimb&uuml;rger O, Stenvinkel P, et al. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int 2003; 23:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/52\">",
"      Harty JC, Boulton H, Venning MC, Gokal R. Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients? Miner Electrolyte Metab 1996; 22:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/53\">",
"      Jones CH, Wells L, Stoves J, et al. Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 2002; 39:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/54\">",
"      Dumler F. Hypoalbuminemia is a marker of overhydration in chronic maintenance patients on dialysis. ASAIO J 2003; 49:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/55\">",
"      Ate�� K, Nergizo��lu G, Keven K, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/56\">",
"      Davies SJ, Brown EA, Reigel W, et al. What is the link between poor ultrafiltration and increased mortality in anuric patients on automated peritoneal dialysis? Analysis of data from EAPOS. Perit Dial Int 2006; 26:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/57\">",
"      Woodrow G. Methodology of assessment of fluid status and ultrafiltration problems. Perit Dial Int 2007; 27 Suppl 2:S143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/58\">",
"      Konings CJ, Kooman JP, van der Sande FM, Leunissen KM. Fluid status in peritoneal dialysis: what's new? Perit Dial Int 2003; 23:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/59\">",
"      Warren PJ, Brandes JC. Compliance with the peritoneal dialysis prescription is poor. J Am Soc Nephrol 1994; 4:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/60\">",
"      Burkart JM, Bleyer AJ, Jordan JR, Zeigler NC. An elevated ratio of measured to predicted creatinine production in CAPD patients is not a sensitive predictor of noncompliance with the dialysis prescription. Perit Dial Int 1996; 16:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/61\">",
"      Nolph KD, Twardowski ZJ, Khanna R, et al. Predicted and measured daily creatinine production in CAPD: identifying noncompliance. Perit Dial Int 1995; 15:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/62\">",
"      Szeto CC, Lai KN, Wong TY, et al. Measured-to-predicted creatinine generation ratio increases with time and decline in residual renal function in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1999; 34:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/63\">",
"      Stojimirovic BB, Blake PG, Oreopoulos DG. Assessing compliance with peritoneal dialysis. Int J Artif Organs 2001; 24:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/58/1962/abstract/64\">",
"      Sarkar S, Bernardini J, Fried L, et al. Tolerance of large exchange volumes by peritoneal dialysis patients. Am J Kidney Dis 1999; 33:1136.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1968 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-2A3F076F4F-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1962=[""].join("\n");
var outline_f1_58_1962=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SOLUTE CLEARANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Kt/Vurea and creatinine clearance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - CANUSA study",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - ADEMEX and Hong Kong trials",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - 2006 K/DOQI guidelines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Automated peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Peritoneal membrane transport",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Peak BUN as determinant of well-being",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CALCULATION OF SOLUTE CLEARANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Weekly Kt/Vurea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Residual renal function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Peritoneal creatinine clearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Differences between small and middle molecular weight solute clearances",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      FLUID BALANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PATIENT COMPLIANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Minimal total solute clearance target values",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Calculation of solute clearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Fluid balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/1968\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/1968|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/49/20253\" title=\"figure 1\">",
"      Risk of mortality among dial pts according to baseline albumin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/57/30622\" title=\"figure 2\">",
"      Predicted survival of PD pts according to KtV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/22/38254\" title=\"figure 3\">",
"      PD survival and creat clearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/39/44670\" title=\"figure 4\">",
"      Solute clearance over time PD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35190?source=related_link\">",
"      Calculation of the creatinine clearance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6378?source=related_link\">",
"      Kt/V and the adequacy of hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=related_link\">",
"      Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/10/14501?source=related_link\">",
"      Patient information: Peritoneal dialysis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/43/16051?source=related_link\">",
"      Patient information: Peritoneal dialysis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=related_link\">",
"      Patient survival and maintenance dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5623?source=related_link\">",
"      Peritoneal equilibration test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23337?source=related_link\">",
"      Problems with solute clearance and ultrafiltration in continuous peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/17/277?source=related_link\">",
"      Protein catabolic rate in maintenance dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/24/37258?source=related_link\">",
"      Uremic toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26868?source=related_link\">",
"      Why Kt/V and creatinine clearance may not correlate in continuous peritoneal dialysis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_58_1963="Bruises child abuse";
var content_f1_58_1963=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Patterns of bruises suggestive of child abuse",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Bruising in babies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bruising in children who are not mobile",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bruises to the face, back, abdomen, buttocks, upper arms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple bruises in clusters",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple bruises of uniform shape (may carry imprint of the object)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Loop marks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ligature marks",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Leslie Raffini, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1963=[""].join("\n");
var outline_f1_58_1963=null;
var title_f1_58_1964="Adjuvant analgesics";
var content_f1_58_1964=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56216&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56216&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adjuvant analgesics",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       For neuropathic pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Desipramine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nortriptyline",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Duloxetine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Venlafaxine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Gabapentin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pregabalin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Baclofen",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mexiletine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Clonidine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tizanidine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ketamine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dextromethorphan",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Topical agents",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Capsaicin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lidocaine patch",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       For bone pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Corticosteriods (eg, dexamethasone, prednisone)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Osteoclast inhibitors",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Calcitonin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Bisphosphonates (eg, ibandronate, pamidronate, zoledronic acid)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       For bowel obstruction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Anticholingergics",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Glycopyrrolate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Scopolamine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Somatostatin analog",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Octreotide",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1964=[""].join("\n");
var outline_f1_58_1964=null;
var title_f1_58_1965="Salient differences";
var content_f1_58_1965=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F76122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F76122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Salient differences in neonatal immune system in comparison to adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"       T-cells",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Overall number &gt; adults",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       CD4+ cells",
"      </td>",
"      <td>",
"       Circulating number &gt; adults; preterms have higher numbers",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       80 to 90 percent are of naive phenotype (CD45 RA)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Possible immature, transitional stage",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CD8+ cells",
"      </td>",
"      <td>",
"       Circulating number &lt; adults; no significant change with gestation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CD4:CD8 ratio",
"      </td>",
"      <td>",
"       Higher than adults",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Proliferation",
"      </td>",
"      <td>",
"       Variable; comparable with mitogens (except in preterms), lower mixed lymphocte reaction, monoclonal antibody responses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Cytokine production",
"      </td>",
"      <td>",
"       Comparable proinflammatory cytokines",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lower antiinflammatory cytokines",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lower concentrations of cytokines involved in adaptive immunity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Responses to antigens",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tolerance induction with superantigens",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       B-cell stimulation",
"      </td>",
"      <td>",
"       Poorer, with less cytokine secretion, lower CD40/CD40L interaction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CTLs",
"      </td>",
"      <td>",
"       Lower cytotoxicity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       &Gamma; T-cells",
"      </td>",
"      <td>",
"       Lower cytotoxicity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Limitations in repertoire",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"       B-cells",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Circulating B-cells",
"      </td>",
"      <td>",
"       Higher numbers than adults",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mostly B1 phenotype",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Function Ig production",
"      </td>",
"      <td>",
"       Mostly IgM secreting",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Impaired isotype switching",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inability to react to certain antigens",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"       NK cells",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Circulating NK cells",
"      </td>",
"      <td>",
"       Immature, transitional stage",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Function",
"      </td>",
"      <td>",
"       Lower cytolytic activity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"       Monocytes and macrophages",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Circulating monocytes",
"      </td>",
"      <td>",
"       Relative monocytosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Function",
"      </td>",
"      <td>",
"       Lower production of certain cytokines; diminished T-cell activation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Reduced chemotaxis. Phagocytosis, microbicidal activity comparable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Diminished delayed-type hypersensitivity (DTH) skin test reactions to antigens",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"       Dendritic cells",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Function",
"      </td>",
"      <td>",
"       Poorer antigen presenting function and T-cell activation",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1965=[""].join("\n");
var outline_f1_58_1965=null;
var title_f1_58_1966="Culprit lesion after CABG";
var content_f1_58_1966=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Graft versus native vessel disease as cause of unstable angina after CABG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 295px; background-image: url(data:image/gif;base64,R0lGODlhHwInAcQAAP///w0N//8AAICAgAAAAAYGf38AAIiIiDMzMxEREXd3d6qqqu7u7lVVVczMzERERCIiIpmZmWZmZru7u8DAwN3d3UBAQAMDPz8AAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAfAicBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5ulQHBL4NIgq+vgi7xsdeCgsAwgfMBArI0tNbEtDPxA7U29xOvQTaIxEEEN3m50MMD77OJAwECSMUA/T1FOj4+S8J8BEjDcvGARMxr94ACwP0KVxogt+weMJ+MUhBj6HFizMqYtzIkWLCjiBDagxJEuPIkigV/55MydIcBYQtY7qEKRNfgnhXerXDtLJmrQrr4FVAcbNFMwD8Jg7RqamnT1kMICRYtmBgQ5z7CCgVwjST06ewxklwBw9AL2BFhSHwFU1YgwQKdDYYFi0YgbE6GcwltywiAWB+gUWA8MssAWeBKX0F6+roiHfxziKFeBjA2gl+41ZO6q6oVABzF1TgS6CYiAWlRzhIbS2CTtSmKy1m/OIAvwT+QA9rN+6viAPlDPUa+7is5LSVQztmypnEXGvRHA5Tt5s6u2908watPGk2bRaoH1gGB3roZaQKJhCYwCDBTkJRpwKoCpnBccoHooJbvpnAUBLq+aLNXLmRgFpw85GzWv9shu10oGIffTfDUV2JsNYC7xyw2gEKIPANcYMA5UsCQ0W0DlqUOeQPf858U9cIaw2k10PYIbBAjQERdt1hOE7yUoQSxiBZhesEB5d6C7h32DgTVOKYRT8GSUNQhPnjAGEJhNNbAw0gsNoCXzrJ3UXeSanClcWsVlo4JKzmwGgHMGlmIGXOWYJDEkyk5jBWAfDAQC7aCUidghbqFZCGJuoJoYo2Cgmjjka6CKTfFWTQpZhmquk9ksoRpaQDXFDAqKSWauqpqI56AaKdtvFppAMUEMCstNZq6624zloAq3BYqumvA3CKEqW0xZrrscjSuqsdoabqrKq8dkQsY8Yma+3/rcvWUe21tWY7bLSFbsvttd7OIe645ZI0LVjnjotsunG0Sy64G637lLzu4govHPgmu6+09NrZb77dBrzGwMf+u9GrjiJMcAAKt+GwvgZH0dt7lDDc6MT5RswGx7Z6LMI6ua2DMQCQ/ZBAOQteYq9PIKNbcRoxK1vxOOK1l8BWRLyTZmqWvFxTzfMyKyvBIotwk32+zcjXZM88wE+fhsEDDWTrtMcnUsN0vQyEoKDWdTQMWOPLRFv+hqAWRFubNM1HdzyzNQecF9po5SDnDD9srlZOLwq8M90IhE3QcsuAYCdjUA/8d4LQjRC2DAJZknDkeu2dfEXb/s6MRttvq0eY/5Fda6X3eGwOeXVZdg0DZmqI/6HMM86EFrsJkC8imei+PMBAhht2+CHbcT+c69ufFy/zCzq2Q6Dl+KE+gnrFAJ6yYeLZDjs5hEDH9UTN4e75JFprAzgAdKOHpJJxrpcF5++Obwbonn/zn9Nlnb4Wm9isFTjrDFhLAi6EuL187Q/fcMD1wleC3CVCGMQRS4IE84sufSlMWIBfwuRXBvo1gWSUsE47ONMcXx2Eg49Yzc5E0B4IlG1MAHATnOSUQeUZL2QoHIMHk7AWtlTiNgUKDfXkcSmafGIdL5pP80rwp9/48H02vKHNjPYw5NVCOmWxTuM80ikNHi+HYtjht7oYRf8pQgyMYRBjSRzIEi9SjIpIQ2M32JgSN2JLjl9o1rNStao24jEmdsShHUwILEwJa41/FAQhC8nIQ1ohkAVrVRw0FjRR7fGSpOojFM34Rkm+gZKyKWMVEwkESE7Rk2+g4x8gaUUlmFJXpEQlFVTpB1bG0gevPKMsj3CA/DQxCLTsgy2Jx8k77tIIEDjAXjSng2DyYZibLGYkj5kOAiwAAQiQAIN64Mw9QLOG0pwmHRbJSHo40hVwgUaHgHnLWooyjsQMJyyZhQED2POe+MwnPjHQzkqY7ZpU40E39fDNzb3TeK3soAEEwNCGOvShDjVAPylxowgEkH88AKViDuquhCL/IZce1eFCIUrSh0p0Fgioyzp/oNHucHR50ZRnSMM40pLa9KSwmADlIIDNAbJzEwV95Evlxqya2pSkOH2F2B5SIFxO1JtDLVpMwznTNBr1qCZ9aiTKlh+e/WCgeQhqFUCq1VleFasNTSos7KOAtjIzB2DFg1hnGVWY0mEAZ0WrANSaAjVFAzUBVZpWaNcDBq5hO0D7alnlWtfOxVOmi5UCXvUKUb6iYE8OACxRBgsEw6bBZwsIbZNKGVk4FrOqRCBrUSmb1Rb4rTSa3QsBGidbzdSNAP5YhwMcwDjHVY0vWJstXX7rjBhZk3vqCWwVUlqEuN5hrlNQrbbyilbLnmA1/w2wxomc05+JvGa2oxGPVBggQRP0wndd05p3r0GYCvTQmheyxmi1IAEItDUuQGipJKAr2cZK9a7Uxap1TYBd/fgGOMPlDFMIY43XdY1BC9gOAq73Pd14bX9OfMs2sfDexPZAv5HgbxSkC2DWRrRi2E3QX1RomOj4p0FVC45UfDsCfhiuNBTmx1CGQwIMi0BHTc3CBEIr2p82xb8bfCxVSwuFyZqYoQMuQYp1A4y9+K9qtkUZP9rB262N4BtrmTDrsPxbcPj4GWvbQgUwhCEjewXJX1SyNFGbxwAfNcppeNIWvnFNEDkVqHDuJDjlqcvpPhnKTF7C0rzAUwgsYKWKBf/0kuV82kQ7wclPxjMq3nHNBWjTzTwJtDGnOmdLNwHTJtY0KiCgTQUkwM/cNHW8RC1IUld6tYdW9Sl6I5T8GjHUk7Y1J+nsBVSzVtenwMwBaJzRX7uM1uI0KKELfdd66vPa+eRnLBRQAQ7d9604cK5phy3rF5B4DuQs5zlVwekOb3gH4tYWtE85aMhSUwgYGjKR5/vnIwe73v++NxAm8B+Cg/rZARfqtIkt8BQwlxnvLkF8RuAXDzew3Kmc9zyFbUaGN7wEOl1ZTyNO8RGVPIkoiPddNU5taRPa4x8fwVJHFGSiYMUvXuKiv0tNaXLH3Adc/d0+sCIO7hGkiBh3g4j/m8xyev+8B7/zagqKIvExm9DZQWM5zHHZ9I0/fQe2GQbJofePgPgm5UmXmNbTvoJzfx0HECAM5ZRb8t1g4y9SH4HKzbX2nnec7YrKkFYkQPdwA14NS3+C299eg3YroEsHz3rCx9r1ljPeBghoQERgLdDDw23ydF245xvVSyHsXQ6Jv3Tlt/71CMSF2Z2XNM85LkXW/9xs8MDoDkD8qL7T/oa2//g7ABKBBIiHpVgPJeiju/rRF8pGwRj7DU4/6+X3V/SXz4EEHtDWB3Af3DWgPr98D/DZZx/zpbN4M50/P/K73N7nt4G+ibwAfsOb/R10v8Jfjv/4i0/2t/Z7CNV///5HAuKXcdY3Ys1XgDLAbUbAe4+Qeqe2gAz4Ao5HBBDoCBLIBItXgSqwMiKHTZx3fwDocwI4Sh5YG1ikfiS4cwFYfi+Ygi0gAV2Vdy34ZgnIdNgngzBQf0NwgEqnf5S3gzzIAg7gEBMWecpnfu+Xg0X4Y/YlAQlQeNNHgGEkhKHHf0+4ApwWfUq4UU6oekS4hSgAAcSXeb5mhWmEhcw3hmRoXg+hezqQgY2wgUvQgW84Pa9nemoIBnboShSYh6fWh3nEhtenhYI4iDQgOK5jHdyRNmaRZgdjiArohon4UTkkOFvBWxNxHpfDHu4xfmE4gZaYiBIwgv0mA4x4DT22M//AcxjC4wuomH+jyIGBeIkiAHmphUdrkRt7QRyXkyQ6QUOIR4k6iIi4+Btw4VZfCAN69jxbYkHWhEHFWIt3eIu46G5pSANVYSHgcADEAUKqAQ4z5D6TaI2AWIqCOH8+iHw5VAE6AgFWoiMw5CeA8kTnyIT7B3/JKAJrxgBtRlol+Hd+V3uESBt8lk3NuF/GqHjYeImN9mjSZwNAqHbomAR4+Ibt5mkTOXEs1Fs6FwXrUAwzdw2QCBxZGIP7eJEVyGop9WorEBFYoT0kV5EUxw/bJDnqgzmh2Ib6OITImIy8RiItQHUV5lkiQCnpVk6XIizFNw4MIhmvyCEeIouV+JP/KcmSFahssHcCVLdAnHV18qNHmPQsmqQeERA75aM06WFN7EOMpIiVPsmP/eh6y+YCRklCYYl0MWBH2SJbxGAXIBKNXjKN1nSMKgmUdImLuFc5LGCUQsSCSTmW85YuiKNCUidDS2KOYiiXh7iYiTh8C1B8x5cCFecMWtSVAEApfokoiINEJ/BLgYKYJgiDtZmMjuaFAgkDrWmRnnmVoJmH3cd9CuB9C/k4lXmQ5taQnRmcZLiKYnecuJOcvpmYWfmbT0h/+yadDUSdH8Occemc/cidBliZCMGUhbRu16iVRpCRbxhh2KSQ7tiXlWlt2Haf+qRtwHmbK4mdW4hFE0kD/3SYlJVpZ8d2eH+IkQ+ZiK8WdXxIn6dloJSFbKkFnraojnl4AA+wnbu5nBF6aEiFoBa6nkHJmA9GnnpXoCBaWSLKns21oHnoM9+GogT6oSt6Yp/Jn4rpovH3ALMYe7ypojeaVi3qn83Jo+enYSJIo6sppEO6V0VqnXOJpNmnjR3qAn4poXpFoT84oulYorgYdTaYAwPapDb6pFxqel6qoBj6ht7GjPMZpGc6pGkKTGv6UTCah1YaaXI6bFpaXVGqo9cppXk4fz3Jpx7qp0+KaDlKkCcIT+PZY6WZiljqpHQaqI5qm5majN5mDQFKA6xpqTdap6XkfrL1HiMpAicpif/NlKdv2GE1d4OVOqejiqkG6RzmYY6uBjSfmDml2qZkOH9yKKstkKWLCqWNeqsmcCEA8JSpMZWxeBfc5KrZeV8zGqeJ2nF/KmC2CnysUiQAgJaIE4xvyZlwRa1FWHGBia2zqqiLSqpf5X5XknsWFp2EeUGHCW/oyoNrdiNYAn4USZm0uqLwynX/piY51yYWp5ntY3/Tt69FGHYNoJpwJbDuiqbdOoDj2DVWcTv26ESsqK/AWoQOEGYHxKTG+q4Zi4KPSlTJGBHxKZ+I2q7aeqwFO61Uaqcjy4PqKpkVC6EXe6nJ6q0FSbT9KKZCh7KiSrArC6maqqyR2lwWW7MqO7T/CHWe6JmeOAumUcuuxbq0IHqzAqV1BGCf+Hm29qSfIsu1XfthyacCKYuxVltFBLCt3Lq14tm2xMoCcSu0+9lxdXusyDq2O6u3AQu0VCu3f1t7gWuzt+Sehmt4iFt7dntTTdsxjVu1hMu2kasCFVeTU0u5jju3SJO5iru2edu5JyAMKPc4oQt8lVtSYou6w2a6fku7Rqq6dbcmIUmzoqu5tAm4sSu7jwuxuksC44AgYjm5sDu6iwt8tlureJuzUUthy9uniXu7DklV0cu005u7xwsQzXp2rsu8CDW8LEq6mIu+6bu5qXu8u9sAYxqqAxu2l9tR3Wu/30uo8JsRr3u+/84bvIzLvq3lvtTbv/QbtNL7vAiVv7lWvIXbv8X6v1VEwESqvvhrwRdswOArwW1HwUijwYMrwNArwiPcqhHswXALwh0jwrOLwnPmwJkGwZyrwi5Qpn27wCTcwCb8wuWZwjZsAjgMtg+Mwegiw6lGw+8bxCtsvhUcwNsbwz2sxAcMvwmcvTocxaeFxAe6v4LKxFjKwh3lwvd7xFPsxZsKxrwpxuhCxkbMLQXAxRNKxXKpOCJgNs5DhYZ7xb97ulpcu2fMwdYpEOhzGEhiGwkyrKrLx80LvH8svILrwylaiir0eCSCGg7QCyVbnL4Qq5HLyADsyEcKyVB8ruooW/J7yP9ToSQTIIX9O8T1W8QMTLeBjLvWyRTrMBZ4bF+9wDRj2rWwrMDeO8ulW8swHJw8xmNfVg5M4soIzMZw7MbEvL6RTMdSint+FhXtEBQnq7ug/MSiHJ6AXM1oDLVqvMZOHMKlLM6kHM4PC8TnvJrQTC7SvMO0TM6C/MXx3LtfG8sz/MbkIsdbas36vM/li719rL2jPMD4bMvDhrVZCyzqGanBjMXDbM/F3NDHTFVmi7Zoq7aGW9EJncULXcIabcovZ8KMusjz7Db1/MgMvc7vnNKCu9Kd+83q7M4kusXGjNIypdInvMct7S8vXdI8fNLhtnpALckViNMtLNM7Pc5QHX7/Sl3TQa23Tj3GU82mUozUM/3TVs3UDJjVbbzVeMq9PZ3UC7fUyikwQ/0uRc3OMa3TVL3WYd3WZiLSjezHRn3PZi0DIMXWqqvXoczXcm3Sf53OI23YbUvW0ZzYL4rWXk2RVV3TYl2Ajk3PkF2hkr3Zvjtngs3Siq3VdM3VPD3ZdU3Tlo3XKZGa/My3RPzP05zBqA2qlV3bKUiTr912sZ3EAO02Ag2o5bzXnh1/emmDme3Sxa2zXb3cvG3Xqy2IYIncb50wcX2hzV3aGXHbzn15x310BmEBEF1OFmBJZeksF9DRHn1tGDDeEf3ewFLe531JF1C26/3R7g3f4W3e871H/+l93x7d3lrLgJEZG1eX3/qd4Aq+4Aze4A7+4BAe4RIe3qy9EK6Ndgb9f7hok01d4X6U4ReXjBw+1h5eRyUuSyMuKBQw0ee84iD+4jAe47h4MTZAHUS3BjTeeOtw41eQ44u44y+uNZN6AyuDA0xxPkwg5DtQ5Ddw5CF7A0quA0xuA07eukyMHRRrgT77AsKwDEi+BFieAz6DA13eYjoQ5jgw5jdQ5l9+zmHGit/AD9EwGIWBvA6BFoPjjzueFG4BF9jhaNiBWL8cBG9eF3FukjpCNcVXGNKxFSJyE1rR55rhC4A+DIKOA4UOsnLerIleAovuG40+Ao/O53/h58NQ6f+9k17n7Dd+E0PcAzgt0xrjWD3Q4LFzsTeRPlxOlD2H2eZIwOrc0+qwzhq4NestZuvdlRlfNlu64eVPXgPAzjKvXuvEXiAtM+zbdOvfo+y73uxmHs+45ws3cmDQgB34eD6w4bF8s+3cEWHRGRrfrgThbk2qM+m6bubpbnHrTurt4O6BCe++TgPzPu7AADjmHrLovib6Th78fhoS5u0BH8Trfl5DhO3XlRoWTwLrsAwNzzU3VgwAL62KRh4Uj/HU/m7XfvJMdJgdb2MtE/I/mhXmM1sVr/IEZvIK4LEbz+4jtB4v3+sir8a9YBpaUwEwi+h2Jw544urbVLKl0fFglhr/8B5AZ5MEQ89COnb0c06P7/HpY+GxTk85ud4OUQ/yh0n1nEUDV69l/qH1nJ70qrr0YB9mUE8MUn/2PTTo5yyOOiA6h1XsO+D3V8D3OSD4Mj4D72XlM7BUCWsGia8DjK/ITPD4ORD5h3/5mJ/5mp8FEab4bJBS3bz5VOAA4vu5flABZvMAO2H6Z3BbcOFbyaX07CD6RBAB67BFrEsIytTJz+D5ZGD0o+ONZ/fzoU/7Z04YD8AmOMc/JuMn4NBl4MU1hQEb2OT0AuIFu1/sy6/xlaFb0L9F0gEM1O8l7yX5PQD8Rufq9xgNX+73sY8dLXLqk/MX1vTpPB7jYlP847s2/7ABAhXxAFDCRIQEsCUxLYSMIETU4rm+873vVySyx0GXguBiCBHJhFLhIK/YrHb7YbOtQy2hqOAchAZLQSgeCApcbSGcpNdSMCtNqsliCbq27/8DBgoOEhYaHiIm5hxIPTjoMBAk5Eg1ECyIycwAmGkuxJABpMwwKJqyLDys8URORo1dZmoicGpegrKMEiCUnuogKCzsiIXGARhvjSXQWtp+PswC1DwCCMmE+mZrb3N3e3/7RUA/gDUIp2DXySCV7CWTWH6O5ViBm5qLzuOkEbCb8NkBEA8XGxv2hukTQwuasFcG06xokeCFQmkEqLFgMJHPwY4eP4IM6csBvk5jeta10HiGhQNo1xh0aUNwooyIIn9QsVXEZAOUGScWAdBSU8+Yt/TRhOINjyZXTC+KohkUhxl2x2w54FeD1jShTafeDCt2LNmyOTS6MisWrdpuZsC2jSt3Ll2PyOraVYPXVIITe/8CDix4MOHChg8jTqx4MePGjh9Djix5MuXKli9jzqx5M+fOnj+DDi16NOnSpk+jTq16NevWrl/Dji17Nu3atm/jzq17N+/evn8DDy58OPHixo8jT658OfPmzp9Djy59OvXq1q9jz659O/fu3r+DDy9+fNwQADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among patients with unstable angina who have had previous coronary artery bypass surgery (CABG), the older the saphenous vein graft, the greater the likelihood that the symptoms result from a culprit lesion within the graft (solid blue columns) rather than from a lesion in a native coronary artery (red columns).",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Chen L, Theroux P, Lesperance J, et al. J Am Coll Cardiol 1996; 28:1493.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1966=[""].join("\n");
var outline_f1_58_1966=null;
var title_f1_58_1967="Nodular anterior scleritis";
var content_f1_58_1967=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F55940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F55940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nodular anterior scleritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 335px; height: 215px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nodular anterior scleritis in a patient with rheumatoid arthritis. Nodular elevation of the sclera is surrounded by deep scleral vascular engorgement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of M Reza Dana, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_58_1967=[""].join("\n");
var outline_f1_58_1967=null;
